CN117242081A

CN117242081A - Organic molecules for optoelectronic devices

Info

Publication number: CN117242081A
Application number: CN202280029925.1A
Authority: CN
Inventors: S·塞弗曼; S·杜克
Original assignee: Samsung Display Co Ltd
Current assignee: Samsung Display Co Ltd
Priority date: 2021-04-23
Filing date: 2022-04-25
Publication date: 2023-12-15
Also published as: US20240237532A1; WO2022223842A2; WO2022223842A3; EP4326733A2; JP2024514692A; KR20240000461A

Abstract

The present invention relates to an organic molecule, in particular for application in optoelectronic devices. According to the invention, the organic molecule has the structure of formula I:wherein R is ¹ And R is ² Independently of each other selected from the group consisting of: c (C) ₁ ‑C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₆ ‑C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the And R is ^H Selected from H, D, F, br, I and C ₁ ‑C ₄ Alkyl groups.

Description

Organic molecules for optoelectronic devices

Technical Field

The invention relates to organic molecules and to the use of organic molecules in Organic Light Emitting Diodes (OLEDs) and in other optoelectronic devices.

Background

Disclosure of Invention

The object of the present invention is to provide organic molecules suitable for use in optoelectronic devices.

This object is achieved by the invention by providing a novel organic molecule.

According to the invention, the organic molecules are pure organic molecules, i.e. they do not contain any metal ions compared to the metal complexes known for use in optoelectronic devices.

According to the invention, the organic molecule exhibits an emission maximum in the blue spectral range or in the sky-blue spectral range and in the green spectral range. In particular, the organic molecules exhibit an emission maximum between 420nm and 560nm (in particular between 420nm and 520, preferably between 440nm and 495nm, more preferably between 450nm and 470 nm). Specifically, the photoluminescence quantum yield of the organic molecule according to the invention is 50% or more. The use of organic molecules according to the invention in an optoelectronic device, such as an Organic Light Emitting Diode (OLED), results in a higher efficiency of the optoelectronic device or a higher color purity as represented by the Full Width Half Maximum (FWHM) of the emission. The corresponding OLED has a higher stability and comparable color than an OLED with known emitter materials. An OLED having a light emitting layer including an inventive organic molecule together with a host material (specifically, with a triplet-annihilation host material) has high stability.

The organic molecules of the invention comprise or consist of the structure of formula I:

wherein,

R ¹ and R is ² Each otherIndependently selected from the group consisting of: c (C) ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ ；

R ^H Selected from the group consisting of hydrogen, deuterium, F, br, I and C ₁ -C ₄ Alkyl groups;

n, m, p, q is an integer selected from 0 and 1,

wherein n+m=1, and p+q=1;

r is an integer selected from 0, 1, 2, 3 or 4 at each occurrence;

s is an integer selected from 0, 1, 2 or 3 at each occurrence;

z is independently selected at each occurrence from the group consisting of direct bond, CR ³ R ⁴ 、C＝CR ³ R ⁴ 、C＝O、C＝NR ³ 、NR ³ 、O、SiR ³ R ⁴ S, S (O) and S (O) ₂ A group of;

R ^a 、R ³ and R is ⁴ Independently at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；B(R ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ ；

R ⁵ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁶ ) ₂ ；OR ⁶ ；Si(R ⁶ ) ₃ ；B(OR ⁶ ) ₂ ；B(R ⁶ ) ₂ ；OSO ₂ R ⁶ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁶ And wherein one ofOr more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁶ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁶ ；

R ⁶ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; OPh; CF (compact flash) ₃ ；CN；F；C ₁ -C ₅ Alkyl, wherein one or more hydrogen atoms are optionally independently replaced by deuterium, CN, CF ₃ Or F substitution; c (C) ₁ -C ₅ Alkoxy, wherein one or more hydrogen atoms are optionally independently replaced by deuterium, CN, CF ₃ Or F substitution; c (C) ₁ -C ₅ Thioalkoxy groups in which one or more hydrogen atoms are optionally independently replaced by deuterium, CN, CF ₃ Or F substitution; c (C) ₂ -C ₅ Alkenyl wherein one or more hydrogen atoms are optionally independently replaced by deuterium, CN, CF ₃ Or F substitution; c (C) ₂ -C ₅ Alkynyl, wherein one or more hydrogen atoms are optionally independently replaced by deuterium, CN, CF ₃ Or F substitution; c (C) ₆ -C ₁₈ Aryl optionally substituted with one or more C ₁ -C ₅ An alkyl substituent; c (C) ₂ -C ₁₇ Heteroaryl, optionally substituted with one or more C ₁ -C ₅ An alkyl substituent; n (C) ₆ -C ₁₈ Aryl group ₂ ；N(C ₂ -C ₁₇ Heteroaryl group ₂ The method comprises the steps of carrying out a first treatment on the surface of the N (C) ₂ -C ₁₇ Heteroaryl) (C) ₆ -C ₁₈ An aryl group);

wherein the substituents R ^a 、R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ And R is ⁶ Any of which may be independently substituted with one or more substituents R ^a 、R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ And/or R ⁶ Forming a mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system.

In one embodiment, the organic molecule comprises or consists of a structure of formula Ia:

wherein R is ^c Independently at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；B(R ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ ，

And wherein the above definition applies.

In yet another embodiment of the invention, R ^c Independently of each other at each occurrence selected from the group consisting of: hydrogen; me; ⁱ Pr； ^t bu; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph,

and wherein the above definition applies.

In one embodiment, the organic molecule comprises or consists of a structure of formula IIa, formula IIb, formula IIc, or formula IId:

in one embodiment, Z is selected at each occurrence from the group consisting of a direct bond, NR ³ Group consisting of O and S.

In a preferred embodiment, Z is a direct bond at each occurrence.

In one embodiment, the organic molecule comprises or consists of a structure of formula IIa-2, formula IIb-2, formula IIc-2 or formula IId-2:

in preferred embodiments, the organic molecule comprises or consists of a structure of formula IIa-2.

In a preferred embodiment, at least one mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system is formed by substituents R ^a 、R ³ 、R ⁴ 、R ⁵ And R is ⁶ With one or more further substituents R ^a 、R ³ 、R ⁴ 、R ⁵ And/or R ⁶ Together forming.

In one embodiment, R ^a Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyrimidinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; carbazolyl groups optionally substituted independently of one another by Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; n (Ph) ₂ Optionally substituted with one or more substituents independently selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph;

wherein two or more adjacent substituents R ^a The connection point for the ring system may be formed selected from the group consisting of:

wherein each dotted line represents the attachment of one of the ring systems shown above to two adjacent substituents R ^a Is a direct bond of the position of (a).

In one embodiment, R ^a Independently of each other at each occurrence selected from the group consisting of: deuterium; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyrimidinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; carbazolyl groups optionally substituted independently of one another by Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; and triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph;

wherein,two or more adjacent substituents R ^a The connection point for the ring system may be formed selected from the group consisting of:

In certain embodiments, if R ² Is that ^t Bu group, R ^a Not forming a part including C as shown ₄ Benzo-fused ring systems of benzo-fused rings and

if R is ² Is a substituted benzofuran radical, R ^a Not forming a part including C as shown ₄ Benzo-fused ring systems of benzo-fused rings:

in yet another embodiment of the invention, R ^a Independently of each other at each occurrence selected from the group consisting of: hydrogen; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the Pyridinyl, optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the Pyrimidinyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the Carbazolyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the Triazinyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the N (Ph) ₂ Optionally substituted with one or more substituents R ⁵ ；

Wherein the radicals R are positioned adjacent to one another ^a Optionally in combination with each other and form a ring system selected from the group consisting of:

wherein X is ¹ Is S, O or NR ⁵ 。

In yet another embodiment of the invention, R ^a Independently of each other at each occurrence selected from the group consisting of: hydrogen; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyrimidinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; and triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph.

In yet another embodiment of the invention, R ^a Independently of each other at each occurrence selected from the group consisting of: hydrogen; me; ⁱ Pr； ^t bu; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph.

In a preferred embodiment, the organic molecule comprises or consists of a structure of formula IIa-21:

Wherein two R ^a2 Is selected from R ^a And optionally together with each other form a mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system; and is also provided with

R ^b Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; n (N)(R ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ An alkynyl group, an amino group,optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ 。

In yet another embodiment of the invention, R ^b Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; carbazolyl groups optionally substituted independently of one another by Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; n (Ph) ₂ 。

In a preferred embodiment, the organic molecule comprises or consists of a structure of formula IIa-22:

in one embodiment, the organic molecule comprises or consists of a structure of formula IIa-23:

in one embodiment, R ^H Selected from hydrogen, deuterium and methyl.

In a preferred embodiment, R ^H Is hydrogen.

In one embodiment, the organic molecule comprises or consists of a structure of formula III:

In a preferred embodiment, R ¹ And R is ² Independently of each other selected from the group consisting of: c (C) ₁ -C ₆ An alkyl group; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph,

wherein R is ¹ And R is ² May together form a mono-or polycyclic aliphatic and/or aromatic ring system.

In a preferred embodiment, R ¹ And R is ² Independently of each other selected from the group consisting of: c (C) ₁ -C ₆ An alkyl group; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph.

In a preferred embodiment, R ¹ Selected from the group consisting of: c (C) ₁ -C ₆ An alkyl group; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph.

In one embodiment, R ¹ Is C ₁ -C ₆ An alkyl group.

In one embodiment, R ¹ Is methyl.

In one embodiment, R ² Selected from the group consisting of: c (C) ₁ -C ₆ An alkyl group; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph.

In one embodiment, the organic molecule comprises or consists of one of the structures of formulas III-1 to III-15 below:

/>

In one embodiment of the invention, R ⁵ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyrimidinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; carbazolyl groups optionally substituted independently of one another by Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ One or more of the group consisting of PhA substituent; n (Ph) ₂ 。

Detailed Description

Definition of the definition

Herein, the term "layer" refers to a body having a broad planar geometry. The optoelectronic device may be composed of several layers, which form part of the common general knowledge of a person skilled in the art.

An emissive layer (EML) in the context of the present invention is a layer of an optoelectronic device, wherein light emission from the layer is observed when voltage and current are applied to the device. It is understood by those skilled in the art that light emission from the optoelectronic device is due to light emission from at least one EML. It will be appreciated by those skilled in the art that light emission from an EML is not generally (primarily) due to all materials included in the EML (not due to the particular emitter material).

An "emitter material" (also referred to as an "emitter") in the context of the present invention is a material that emits light when included in the light emitting layer (EML) of an optoelectronic device (see below), provided that a voltage and current are applied to the device. It will be appreciated by those skilled in the art that the emitter material is typically an "emissive dopant" material, and those skilled in the art understand that the dopant material (which may or may not be emissive) is a material embedded in a host material, which is typically (and herein) referred to as a host material. Herein, when a host material is included in an optoelectronic device (preferably an OLED) comprising at least one organic molecule according to the invention, the host material is also commonly referred to as H ^B 。

In the context of the present invention, the term "cyclic group" may be understood in its broadest sense as any monocyclic, bicyclic or polycyclic moiety.

In the context of the present invention, the term "ring" when referring to a chemical structure can be understood in the broadest sense as any monocyclic moiety. Along the same lines, the term "ring" when referring to a chemical structure is to be understood in its broadest sense as any bicyclic or polycyclic moiety.

In the context of the present invention, the term "ring system" is to be understood in its broadest sense as any single, double or multiple ring moiety.

In the context of the present invention, the term "ring atom" refers to any atom that is part of a ring or ring nucleus of a ring system, but not optionally part of an acyclic substituent attached to the ring nucleus.

In the context of the present invention, the term "carbocycle" is to be understood in its broadest sense as any cyclic group in which the cyclic structure comprises only carbon atoms, which of course may be substituted with hydrogen or any other substituent defined in the specific embodiments of the invention. It is understood that the term "carbocycle" as an adjective refers to a cyclic group wherein the cyclic structure comprises only carbon atoms, which of course may be substituted with hydrogen or any other substituent defined in the specific embodiments of the invention.

In the context of the present invention, the term "heterocycle" is to be understood in its broadest sense as any ring group in which the ring core structure includes not only carbon atoms but also at least one heteroatom. It is understood that the term "heterocycle" as an adjective refers to a cyclic group wherein the cyclic structure includes not only carbon atoms but also at least one heteroatom. Unless otherwise specified in the specific embodiments, the heteroatoms may be the same or different at each occurrence, and preferably may be individually selected from the group consisting of B, si, N, O, S and Se (more preferably B, N, O and S, more preferably N, O and S). All carbon atoms or heteroatoms included in the heterocyclic ring in the context of the invention may of course be substituted with hydrogen or any other substituent defined in the specific embodiments of the invention.

It will be appreciated by those skilled in the art that any cyclic group (i.e., any carbocycle and heterocycle) may be aliphatic or aromatic or heteroaromatic.

In the context of the present application, when referring to a ring group (i.e., ring, rings, ring system, carbocycle, heterocycle), the term aliphatic means that the ring core structure (not counting substituents optionally attached thereto) contains at least one ring atom that is not part of an aromatic or heteroaromatic ring or ring system. Preferably, most, and more preferably all, of the ring atoms within the alicyclic group are not aromatic or part of a heteroaromatic or ring system (such as in cyclohexane or in piperidine, for example). Here, when an alicyclic ring or ring system is generally referred to, there is no distinction between carbocyclic and heterocyclic groups, and the term "aliphatic" may be used as an adjective to describe a carbocyclic or heterocyclic ring, in order to indicate whether a heteroatom is included in the alicyclic group.

As understood by those of skill in the art, the terms "aryl" and "aromatic (aromatic)" may be understood in the broadest sense as any monocyclic, bicyclic, or polycyclic aromatic moiety, i.e., a ring group in which all ring atoms are part of an aromatic ring system (preferably, part of the same aromatic ring system). However, throughout the present application, the terms "aryl" and "aromatic" are limited to monocyclic, bicyclic or polycyclic aromatic moieties wherein all aromatic ring atoms are carbon atoms. Conversely, the terms "heteroaryl" and "heteroaromatic" herein refer to any monocyclic, bicyclic, or polycyclic aromatic moiety in which at least one aromatic carbocyclic atom is replaced by a heteroatom (i.e., not carbon). Unless otherwise specified in particular embodiments of the application, at least one heteroatom within "heteroaryl" or "heteroaromatic" may be the same or different at each occurrence and may be independently selected from the group consisting of N, O, S and Se (more preferably N, O and S). Those skilled in the art will appreciate that the adjectives "aromatic" and "heteroaromatic" may be used to describe any cyclic group (i.e., any ring system). That is, the aromatic ring group (i.e., aromatic ring system) is an aryl group and the heteroaromatic ring group (i.e., heteroaromatic ring system) is a heteroaryl group.

Unless stated differently in the specific embodiments of the invention, aryl groups herein preferably contain 6 to 60 aromatic ring atoms (more preferably, 6 to 40 aromatic ring atoms, even more preferably, 6 to 18 aromatic ring atoms). Unless stated differently in the specific embodiments of the invention, heteroaryl groups herein preferably contain 5 to 60 aromatic ring atoms (preferably 5 to 40 aromatic ring atoms, more preferably 5 to 20 aromatic ring atoms), at least one of which is a heteroatom (preferably selected from N, O, S and Se, more preferably from N, O and S). If more than one heteroatom is included in the heteroaromatic group, then all heteroatoms are preferably selected independently of each other from N, O, S and Se (more preferably from N, O and S).

In the context of the present invention, for both aromatic and heteroaromatic groups (e.g., aryl or heteroaryl substituents), the number of aromatic ring carbon atoms may be given as a subscript number in the definition of certain substituents, e.g., in "C", for example ₆ -C ₆₀ Aryl ", meaning that the corresponding aryl substituent comprises from 6 to 60 aromatic carbon ring atoms. The same subscript numbers are also used herein to denote the number of carbon atoms permissible in all other types of substituents, regardless of whether they are aliphatic, aromatic, or heteroaromatic. For example, the expression "C ₁ -C ₄₀ Alkyl "refers to an alkyl substituent comprising from 1 to 40 carbon atoms.

Preferred examples of aryl groups include those derived from benzene, naphthalene, anthracene, phenanthrene, pyrene, dihydropyrene,Groups of perylenes, fluoranthenes, benzanthracenes, benzophenanthrenes, naphthacenes, pentacenes, benzopyrenes, or combinations of these groups.

Preferred examples of heteroaryl groups include those derived from furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5, 6-quinoline, benzo-6, 7-quinoline, benzo-7, 8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthazole, phenanthroimidazole, pyridoimidazole, pyrazinoimidazole, quinoxalinoimidazole, oxazole, benzoxazole groups of naphthoxazoles, anthracenoxazoles, phenanthrooxazoles, isoxazoles, 1, 2-thiazoles, 1, 3-thiazoles, benzothiazoles, pyridazines, benzopyridazines, pyrimidines, benzopyrimidines, 1,3, 5-triazines, 1,2, 4-triazines, 1,2, 3-triazines, quinoxalines, pyrazines, phenazines, naphthyridines, carbolines, benzocarbolines, phenanthrolines, 1,2, 3-triazoles, 1,2, 4-triazoles, benzotriazoles, 1,2, 3-oxadiazoles, 1,2, 4-oxadiazoles, 1,2, 5-oxadiazoles, 1,2,3, 4-tetrazines, 1,2,4, 5-tetrazines, purines, pteridines, indolizines and benzothiadiazoles, or combinations of these groups.

As used throughout the present application, the term "arylene" refers to a divalent aryl substituent having two binding sites to other molecular structures to serve as a linker structure. Along the same lines, the term "heteroarylene" refers to a divalent heteroaryl substituent having two binding sites to other molecular structures to serve as a linker structure.

In the context of the present application, the term "fused" when referring to an aromatic or heteroaromatic ring system means that the "fused" aromatic or heteroaromatic ring shares at least one bond that is part of both ring systems. For example, naphthalene (or naphthyl when referred to as a substituent) or benzothiophene (or benzothiophenyl when referred to as a substituent) are considered fused aromatic ring systems in the context of the present application in which two benzene rings (for naphthalene) or thiophene and benzene (for benzothiophene) share one bond. It is also understood that sharing a bond in this context includes sharing two atoms that make up the respective bond, and that a fused aromatic or heteroaromatic ring system may be understood as one aromatic or heteroaromatic ring system. In addition, it is understood that more than one bond may be shared by the aromatic or heteroaromatic rings that make up the fused aromatic or heteroaromatic ring system (e.g., in pyrene). Furthermore, it will be understood that the alicyclic ring system may also be fused and this has the same meaning as for the aromatic or heteroaromatic ring system, except of course that the fused alicyclic ring system is not aromatic. Furthermore, it is understood that the aromatic or heteroaromatic ring system may also be fused to the alicyclic ring system (in other words: share at least one bond with the alicyclic ring system).

In the context of the present invention, the term "condensed" ring system has the same meaning as a "fused" ring system.

In certain embodiments of the invention, adjacent substituents bound to a ring or ring system may together form an additional mono-or polycyclic aliphatic, aromatic or heteroaromatic ring system fused to the aromatic or ring system to which the substituents are bound or to the heteroaromatic ring or ring system. It is understood that the fused ring system so formed will optionally be larger (meaning that it includes more ring atoms) than the aromatic or heteroaromatic ring system or ring system to which the adjacent substituents are bonded. In these cases (and if such a number is provided), the "total" amount of ring atoms included in the fused ring system is understood to include the sum of ring atoms in the aromatic or heteroaromatic ring system to which the adjacent substituents are bound and ring atoms of the additional ring system formed by the adjacent substituents, however, wherein the ring atoms shared by the fused rings are counted once instead of twice. For example, a benzene ring may have two adjacent substituents that together form another benzene ring so as to constitute a naphthalene nucleus. Because two carbon atoms are shared by two benzene rings and are therefore counted only once, rather than twice, the naphthalene nucleus then comprises 10 ring atoms.

Generally, in the context of the present invention, the term "adjacent substituent" or "adjacent group" refers to a substituent or group that is bound to the same or an adjacent atom.

In the context of the present invention, the term "alkyl" may be understood in the broadest sense as any linear, branched or cyclic alkyl substituent. Preferred examples of the alkyl group as a substituent include methyl (Me), ethyl (Et), n-propyl [ ] ⁿ Pr, isopropyl ⁱ Pr), cyclopropyl, n-butyl ⁿ Bu) and isobutyl% ⁱ Bu, sec-butyl% ^s Bu), t-butyl ^t Bu), cyclobutyl, 2-methylbutyl, n-pentyl, sec-pentyl, tert-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl, sec-hexyl, tert-hexyl, 2-hexyl, 3-hexyl, neohexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctaneBasic, 1-bicyclo [2,2]Octyl, 2-bicyclo [ 2.2.2]Octyl, 2- (2, 6-dimethyl) octyl, 3- (3, 7-dimethyl) octyl, adamantyl, 1-dimethyl-n-hex-1-yl, 1-dimethyl-n-hept-1-yl, 1-dimethyl-n-oct-1-yl 1, 1-dimethyl-n-dec-1-yl, 1-dimethyl-n-dodec-1-yl, 1-dimethyl-n-tetradec-1-yl, 1-dimethyl-n-hexadecan-1-yl, 1-dimethyl-n-octadec-1-yl 1, 1-diethyl-n-hex-1-yl, 1-diethyl-n-hept-1-yl, 1-diethyl-n-oct-1-yl, 1-diethyl-n-dec-1-yl, 1-diethyl-n-dodec-1-yl, 1-diethyl-n-tetradeca-n-1-yl 1, 1-diethyl-n-hexadecan-1-yl, 1-diethyl-n-octadecan-1-yl, 1- (n-propyl) -cyclohex-1-yl, 1- (n-butyl) -cyclohex-1-yl, 1- (n-hexyl) -cyclohex-1-yl, 1- (n-octyl) -cyclohex-1-yl and 1- (n-decyl) -cyclohex-1-yl.

"s" in, for example, s-butyl, s-pentyl and s-hexyl means "secondary"; or in other words: s-butyl, s-pentyl and s-hexyl are equal to sec-butyl, sec-pentyl and sec-hexyl, respectively. "t" in, for example, t-butyl, t-pentyl and t-hexyl means "tertiary"; or in other words: t-butyl, t-pentyl and t-hexyl are equal to t-butyl, t-pentyl and t-hexyl, respectively.

As used herein, the term "alkenyl" includes straight-chain, branched-chain, and cyclic alkenyl substituents. The term alkenyl illustratively includes substituents such as: ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl.

As used herein, the term "alkynyl" includes straight-chain, branched-chain, and cyclic alkynyl substituents. The term alkynyl illustratively includes ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl, or octynyl.

As used herein, the term "alkoxy" includes straight, branched, and cyclic alkoxy substituents. The term alkoxy illustratively includes methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy and 2-methylbutoxy.

As used herein, the term "thioalkoxy" includes straight, branched, and cyclic thioalkoxy substituents wherein the oxygen atom O of the corresponding alkoxy group is replaced with sulfur S.

As used herein, the term "halogen" (or "halo" when referred to as a substituent in a chemical nomenclature) may be understood in the broadest sense as any atom of an element of main group VII (in other words: group XVII) of the periodic table of elements, preferably fluorine, chlorine, bromine or iodine.

It is understood that when a fragment of a molecule is described as a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g., naphthyl, dibenzofuranyl) or as if it were a complete group (e.g., naphthalene, dibenzofuranyl). As used herein, these different ways of specifying substituents or attachment fragments are considered equivalent.

Further, whenever reference is made herein to a reference such as "C ₆ -C ₆₀ Aryl "or" C ₁ -C ₄₀ When a substituent of an alkyl "is not given a name of a binding site within the substituent, this means that the corresponding substituent may be bound via any atom. For example, "C ₆ -C ₆₀ Aryl "substituents may be bound via any of 6 to 60 aromatic carbon atoms," C ₁ -C ₄₀ The alkyl "substituents may be bound via any of 1 to 40 aliphatic carbon atoms. On the other hand, a "2-cyanophenyl" substituent may only be bound in such a way that its CN group is adjacent to the binding site, to allow for proper chemical naming.

In the context of the present invention, whenever substituents such as "butyl", "biphenyl" or "terphenyl" are not referred to in further detail, this means that any isomer of the corresponding substituent may be allowed as a particular substituent. In this regard, for example, the term "butyl" as a substituent includes n-butyl, sec-butyl, tert-butyl and isobutyl as substituents. Along the same lines, the term "biphenyl" as a substituent includes o-, m-or p-biphenyl, wherein o-, m-and p-are defined relative to the binding site of the biphenyl substituent to the corresponding chemical moiety having a biphenyl substituent. Similarly, the term "terphenyl" as a substituent includes 3-o-terphenyl, 4-m-terphenyl, 5-m-terphenyl, 2-p-terphenyl, or 3-p-terphenyl, wherein, as known to those skilled in the art, o-, m-, and p-indicate the position of two Ph moieties within the terphenyl relative to each other, and "2-," 3-, "4-" and "5-" indicate the binding sites of a terphenyl substituent to the corresponding chemical moiety having a terphenyl substituent.

It is understood that all of the groups defined above and indeed all chemical moieties may be further substituted according to the specific embodiments described herein, regardless of whether they are cyclic or acyclic aliphatic, aromatic or heteroaromatic.

All hydrogen atoms (H) included in any of the structures referred to herein may be replaced independently at each occurrence by deuterium (D), unless otherwise indicated. It is common practice for those skilled in the art to replace hydrogen with deuterium. Thus, there are many known methods by which this can be achieved, and several review articles exist describing them.

If experimental or computational data are compared, the values must be determined by the same method. For example, if the experiment ΔE is determined by a specific method _ST Below 0.4eV, the comparison is valid only using the same specific method including the same conditions. To give a specific example, the determination of PLQY values was only performed under the same reaction conditions (measured in 10% pmma film at room temperature), and comparison of photoluminescence quantum yields (PLQY) of different compounds was effective. Similarly, the calculated energy value needs to be determined by the same calculation method (using the same function and the same basis set).

Optoelectronic device comprising at least one organic molecule according to the invention

Yet another aspect of the invention relates to an optoelectronic device comprising at least one organic molecule according to the invention.

In one embodiment, the optoelectronic device comprising at least one organic molecule according to the invention is selected from the group consisting of:

organic Light Emitting Diodes (OLED);

a light-emitting electrochemical cell;

OLED sensors, in particular gas and vapor sensors that are not hermetically isolated from the outside;

an organic diode;

organic solar cell;

an organic transistor;

organic field effect transistors;

an organic laser; and

a down-conversion element.

A light-emitting electrochemical cell consists of three layers (i.e., a cathode, an anode, and an active layer that may contain organic molecules according to the invention).

In a preferred embodiment, the optoelectronic device comprising at least one organic molecule according to the invention is selected from the group consisting of Organic Light Emitting Diodes (OLEDs), light emitting electrochemical cells (LECs), organic lasers and light emitting transistors.

In an even more preferred embodiment, the optoelectronic device comprising at least one organic molecule according to the invention is an Organic Light Emitting Diode (OLED).

In one embodiment, an optoelectronic device comprising at least one organic molecule according to the invention is an OLED which may exhibit the following layer structure:

1. substrate

2. Anode layer, A

3. Hole injection layer, HIL

4. Hole transport layer, HTL

5. Electron blocking layer, EBL

6. Light emitting layer (also referred to as an emissive layer), EML

7. Hole blocking layer, HBL

8. Electron transport layer, ETL

9. Electron injection layer, EIL

10. A cathode layer, C,

wherein the OLED may only optionally comprise each layer except for the anode layer a, the cathode layer C and the EML, wherein different layers may be combined, the OLED may comprise more than one layer of each layer type defined above.

Furthermore, an optoelectronic device comprising at least one organic molecule according to the invention may optionally comprise one or more protective layers protecting the device from damaging exposure to harmful substances in the environment (including, illustratively, ground moisture, steam and/or gases).

In one embodiment, the optoelectronic device comprising at least one organic molecule according to the invention is an OLED which may exhibit the following (inverted) layer structure:

1. substrate

2. Cathode layer, C

3. Electron injection layer, EIL

4. Electron transport layer, ETL

5. Hole blocking layer, HBL

6. Light emitting layer (also referred to as an emissive layer), EML

7. Electron blocking layer, EBL

8. Hole transport layer, HTL

9. Hole injection layer, HIL

10. The anode layer, a,

wherein the OLED (having an inverted layer structure) only optionally comprises each layer except for the anode layer a, the cathode layer C and the EML, wherein different layers may be combined, and the OLED may comprise more than one layer of each layer type defined above.

Depending on the exact structure and substitution, the organic molecules according to the invention (according to the embodiments represented above) can be used in various layers. Where used, the fraction of organic molecules according to the invention in the corresponding layer in an optoelectronic device (more specifically in an OLED) is 0.1 to 99 wt% (more specifically 1 to 80 wt%). In an alternative embodiment, the proportion of organic molecules in the respective layer is 100% by weight.

In one embodiment, an optoelectronic device comprising at least one organic molecule according to the invention is an OLED which may exhibit a stacked structure. In this structure, the individual cells are stacked on top of each other, contrary to typical arrangements in which the OLEDs are placed side by side. The mixed light may be generated with the OLED exhibiting a stacked structure, and in particular, the white light may be generated by stacking the blue OLED, the green OLED, and the red OLED. Furthermore, OLEDs exhibiting stacked structures may optionally include a Charge Generation Layer (CGL), typically positioned between two OLED subunits and typically consisting of an n-doped layer and a p-doped layer and the n-doped layer of one CGL typically positioned close to the anode layer.

In one embodiment, the optoelectronic device comprising at least one organic molecule according to the invention is an OLED comprising two or more emissive layers between an anode and a cathode. In particular, such a so-called tandem OLED comprises three emission layers, of which one emits red light, one emits green light, one emits blue light, and optionally further layers such as charge generating layers, blocking layers or transport layers may be included between the respective emission layers. In yet another embodiment, the emissive layers are stacked adjacently. In yet another embodiment, the tandem OLED includes a charge generating layer between each two emissive layers. In addition, adjacent emissive layers or emissive layers separated by a charge generating layer may be combined.

In one embodiment, the optoelectronic device comprising at least one organic molecule according to the invention may be a substantially white optoelectronic device, that is to say a device emitting white light. Such a white light emitting optoelectronic device may comprise, for example, at least one (deep) blue emitter molecule and one or more emitter molecules emitting green and/or red light. Then, as described in the later section herein (see below), there may also optionally be energy transfer between two or more molecules (energy transmittance).

In case the optoelectronic device comprises at least one organic molecule according to the invention, it is preferred that the at least one organic molecule according to the invention is comprised in the light emitting layer (EML) of the optoelectronic device (most preferably in the EML of the OLED). However, the organic molecules according to the invention may also be used, for example, for an Electron Transport Layer (ETL) and/or for an Electron Blocking Layer (EBL) or exciton blocking layer and/or for a Hole Transport Layer (HTL) and/or for a Hole Blocking Layer (HBL). Where used, the fraction of organic molecules according to the invention in the respective layers in the optoelectronic device (more particularly in the OLED) is 0.1 to 99 wt.% (more particularly 0.5 to 80 wt.%, particularly 0.5 to 10 wt.%). In an alternative embodiment, the proportion of organic molecules in the respective layer is 100% by weight.

Selection criteria for suitable materials for the various layers of an optoelectronic device, in particular an OLED, are common general knowledge to a person skilled in the art. The prior art describes a large number of materials used in the various layers and also teaches which materials are suitable for use alongside one another. It is understood that any material used in the prior art may also be used in optoelectronic devices comprising organic molecules according to the invention. In the following, preferred examples of materials for the respective layers will be given. It is understood that this does not imply that all types of layers listed below must be present in an optoelectronic device comprising at least one organic molecule according to the invention. In addition, it is understood that an optoelectronic device comprising at least one organic molecule according to the invention may comprise more than one each of the layers listed below, for example, two or more light emitting layers (EML). It is also understood that two or more layers of the same type (e.g., two or more EMLs or two or more HTLs) need not include the same materials or even include the same materials in the same proportions. Furthermore, it is understood that an optoelectronic device comprising at least one organic molecule according to the invention does not have to comprise all the layer types listed below, wherein the anode layer, the cathode layer and the light emitting layer will typically be present in all cases.

The substrate may be formed of any material or combination of materials. Most commonly, glass slides are used as substrates. Alternatively, a thin metal layer (e.g., copper, gold, silver, or aluminum film) or a plastic film or slide may be used. This may allow a higher degree of flexibility. The anode layer a is mainly composed of a material that allows to obtain a (substantially) transparent film. Since at least one of the two electrodes should be (substantially) transparent to allow light to be emitted from the OLED, the anode layer a or the cathode layer C is typically transparent. Preferably, the anode layer a comprises, or even consists of, a large amount of Transparent Conductive Oxide (TCO). Such an anode layer a may for example comprise indium tin oxide, aluminum zinc oxide, fluorine doped tin oxide, indium zinc oxide, pbO, snO, zirconium oxide, molybdenum oxide, vanadium oxide, tungsten oxide, graphite, doped Si, doped Ge, doped GaAs, doped polyaniline, doped polypyrrole and/or doped polythiophene.

Preferably, the anode layer a is (substantially) made of Indium Tin Oxide (ITO) (e.g., (InO) ₃ ) _0.9 (SnO ₂ ) _0.1 ) Composition is prepared. The roughness of the anode layer a caused by the Transparent Conductive Oxide (TCO) can be compensated by using a Hole Injection Layer (HIL). Furthermore, because transport of quasi-charge carriers from the TCO to the Hole Transport Layer (HTL) is facilitated, the HIL may facilitate injection of quasi-charge carriers (i.e., holes). The Hole Injection Layer (HIL) may comprise poly (3, 4-ethylenedioxythiophene) (PEDOT), polystyrene sulfonate (PSS), moO ₂ 、V ₂ O ₅ CuPC or CuI (specifically, a mixture of PEDOT and PSS). The Hole Injection Layer (HIL) may also prevent diffusion of metal from the anode layer a into the Hole Transport Layer (HTL). The HIL may include, for example, PEDOT: PSS (poly (3, 4-ethylenedioxythiophene): polystyrene sulfonate), PEDOT (poly (3, 4-ethylenedioxythiophene)), mM DATA (4, 4' -tris [ phenyl (m-tolyl) amino)]Triphenylamine), spiro-TAD (2, 2', 7' -tetrakis (N, N-diphenylamino) -9,9' -spirobifluorene), DNTPD (N1, N1' - (biphenyl-4, 4' -diyl) bis (N1-phenyl-N4, N4-di-m-tolylphenyl-1, 4-diamine)), NPB (N, N ' -bis (1-naphthyl) -N, N ' -bis-phenyl (1, 1' -biphenyl) -4,4' -diamine), npnpnpb (N, N ' -diphenyl-N, N ' -bis [4- (N, N-diphenyl-amino) phenyl]Benzidine), meO-TPD (N, N '-tetrakis (4-methoxyphenyl) benzidine), HAT-CN (1, 4,5,8,9, 12-hexaazabenzophenanthrene hexacarbonitrile) and/or spiro-NPD (N, N' -diphenyl-N, N '-bis (1-naphthyl) -9,9' -spirobifluorene-2, 7-diamine).

Adjacent to anode layer a or Hole Injection Layer (HIL), hole transport is typically locatedLayer (HTL). Here, any hole transport material may be used. For example, electron-rich heteroaromatic compounds such as triarylamines and/or carbazole may be used as hole transport compounds. The HTL may reduce an energy barrier between the anode layer a and the emission layer EML. The Hole Transport Layer (HTL) may also be an Electron Blocking Layer (EBL). Preferably, the hole transporting compound has a relatively high energy level of its lowest excited triplet state T1. Illustratively, the Hole Transport Layer (HTL) may include a material such as tris (4-carbazol-9-ylphenyl) amine (TCTA), poly-TPD (poly (4-butylphenyl-diphenyl-amine)), α -NPD (N, N '-bis (naphthalen-1-yl) -N, N' -bis (phenyl) -2,2 '-dimethylbenzidine), TAPC (4, 4' -cyclohexyl-bis [ N, N-bis (4-methylphenyl) aniline) ]) 2-TNATA (4, 4' -tris [ 2-naphthyl (phenyl) amino)]Triphenylamine), spiro-TAD (2, 2', 7' -tetrakis (N, N-diphenylamino) -9,9' -spirobifluorene), DNTPD (N1, N1' - (biphenyl-4, 4' -diyl) bis (N1-phenyl-N4, N4-xylenyl-1, 4-diamine), NPB (N, N ' -bis- (1-naphthyl) -N, N ' -diphenyl- (1, 1' -biphenyl) -4,4' -diamine), NPNPB (N, N ' -diphenyl-N, N ' -bis- [4- (N, N-diphenylamino) phenyl]Benzidine), meO-TPD (N, N '-tetrakis (4-methoxyphenyl) benzidine), HAT-CN (1, 4,5,8,9, 12-hexaazabenzophenanthrene hexacarbonitrile) and/or Tris-Pcz (9, 9' -diphenyl-6- (9-phenyl-9H-carbazol-3-yl) -9H,9'H-3,3' -bicarbazole). In addition, the HTL may include a p-doped layer that may be composed of an inorganic dopant or an organic dopant in an organic hole transport matrix. Transition metal oxides such as vanadium oxide, molybdenum oxide, or tungsten oxide may be used as the inorganic dopant. Tetrafluorotetracyanoquinodimethane (F) ₄ -TCNQ), copper pentafluorobenzoate (Cu (I) pFBz) or transition metal complexes may be used as organic dopants.

EBL may include, for example, mCP (1, 3-bis (carbazol-9-yl) benzene), TCTA (Tris (4-carbazol-9-ylphenyl) amine), 2-TNATA (4, 4',4 "-Tris [ 2-naphthyl (phenyl) amino ] triphenylamine), mCBP (3, 3-bis (9H-carbazol-9-yl) biphenyl), tris-Pcz (9-phenyl-3, 6-bis (9-phenyl-9H-carbazol-3-yl) -9H-carbazole), czSi (9- (4-tert-butylphenyl) -3, 6-bis (triphenylsilyl) -9H-carbazole) and/or DCB (N, N' -dicarbazolyl-1, 4-dimethylbenzene).

Adjacent to the Hole Transport Layer (HTL) or, if present, the Electron Blocking Layer (EBL), an emitting layer (EML) is typically positioned. The light emitting layer (EML) includes at least one organic molecule (i.e., an emitter material). Typically, the EML additionally comprises one or more host materials (also referred to as matrix materials). Illustratively, the host material may be selected from CBP (4, 4' -bis (N-carbazolyl) biphenyl), mCP (1, 3-bis (carbazol-9-yl) benzene), mCBP (3, 3-bis (9H-carbazol-9-yl) biphenyl), sif87 (dibenzo [ b, d ] thiophen-2-yltriphenylsilane), czSi (9- (4-tert-butylphenyl) -3, 6-bis (triphenylsilyl) -9H-carbazole), sif88 (dibenzo [ b, d ] thiophen-2-yldiphenylsilane), DPEPO (bis [2- (diphenylphosphino) phenyl ] ether oxide), 9- [3- (dibenzofuran-2-yl) phenyl ] -9H-carbazole, 9- [3- (dibenzothiophen-2-yl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzofuran-yl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzothiophenyl) phenyl ] -9H-carbazole, T (2, 6-T-3, 5-triazine) 2-T (3, 3-tri-phenyl) biphenyl, T3T (2, 4, 6-tris (terphenyl-3-yl) -1,3, 5-triazine) and/or TST (2, 4, 6-tris (9, 9' -spirobifluorene-2-yl) -1,3, 5-triazine). As known to those skilled in the art, the host material should typically be selected to exhibit a first (i.e., lowest) excited triplet state (T1) energy level and a first (i.e., lowest) excited singlet state (S1) energy level that are energetically higher than the first (i.e., lowest) excited triplet state (T1) energy level and the first (i.e., lowest) excited singlet state (S1) energy level of at least one organic molecule embedded in the respective host material.

As previously mentioned, it is preferred that at least one EML of an optoelectronic device in the context of the invention comprises at least one organic molecule according to the invention. Preferred compositions of EML of optoelectronic devices comprising at least one organic molecule according to the invention are described in more detail in the later sections herein (see below).

Adjacent to the light emitting layer (EML), an Electron Transport Layer (ETL) may be positioned. Here, any electron transport material may be used. For example, compounds having electron-deficient groups such as benzimidazole, pyridine, triazole, triazine, oxadiazole (e.g., 1,3, 4-oxadiazole), phosphine oxide, and sulfone may be used. The electron transport material may also be, for example, 1,3, 5-tris (1-phenyl-1H-benzo [ d ]]Imidazol-2-yl) benzene (TPBi). ETL (extract-transform-load) capabilityFor example, NBphen (2, 9-bis (naphthalen-2-yl) -4, 7-diphenyl-1, 10-phenanthroline), alq ₃ (tris (8-hydroxyquinoline) aluminum), TSPO1 (diphenyl-4-triphenylsilylphenyl-phosphine oxide), BPyTP2 (2, 7-bis (2, 2' -bipyridin-5-yl) benzo [9, 10)]Phenanthrene), sif87 (dibenzo [ b, d)]Thiophen-2-yl-triphenylsilane), sif88 (dibenzo [ b, d]Thiophen-2-yldiphenylsilane), bmPyPhB (1, 3-bis [3, 5-di (pyridin-3-yl) phenyl) ]Benzene) and/or BTB (4, 4' -bis [2- (4, 6-diphenyl-1, 3, 5-triazinyl)]-1,1' -biphenyl). Alternatively, the ETL may be doped with a material such as Liq ((8-hydroxyquinoline) lithium). An Electron Transport Layer (ETL) may also block holes or a Hole Blocking Layer (HBL) is typically introduced between the EML and the ETL.

The Hole Blocking Layer (HBL) may for example comprise BCP (2, 9-dimethyl-4, 7-diphenyl-1, 10-phenanthroline = bathocuproine), 4, 6-diphenyl-2- (3- (triphenylsilyl) phenyl) -1,3, 5-triazine, 9'- (5- (6- ([ 1,1' -biphenyl)]-3-yl) -2-phenylpyrimidin-4-yl) -1, 3-phenylene bis (9H-carbazole), BAlq (bis (8-hydroxy-2-methylquinolin) - (4-phenylphenoxy) aluminum), NBphen (2, 9-bis (naphthalen-2-yl) -4, 7-diphenyl-1, 10-phenanthroline), alq ₃ (tris (8-hydroxyquinoline) aluminum), TSPO1 (diphenyl-4-triphenylsilylphenyl-phosphine oxide), T2T (2, 4, 6-tris (biphenyl-3-yl) -1,3, 5-triazine), T3T (2, 4, 6-tris (terphenyl-3-yl) -1,3, 5-triazine), TST (2, 4, 6-tris (9, 9' -spirobifluorene-2-yl) -1,3, 5-triazine) and/or TCB/TCP (1, 3, 5-tris (N-carbazolyl) benzene/1, 3, 5-tris (carbazol-9-yl) benzene).

The cathode layer C may be positioned adjacent to an Electron Transport Layer (ETL). For example, the cathode layer C may include or consist of a metal (e.g., al, au, ag, pt, cu, zn, ni, fe, pb, li, ca, ba, mg, in, W or Pd) or a metal alloy. For practical reasons the cathode layer may consist of a (substantially) opaque metal such as Mg, ca or Al. Alternatively or additionally, the cathode layer C may also comprise graphite and/or Carbon Nanotubes (CNTs). Alternatively, the cathode layer C may also include or consist of nano-scale silver wires.

Comprising at least one according to the inventionThe OLED of the organic molecules may further optionally include a protective layer (which may be designated as an Electron Injection Layer (EIL)) between the Electron Transport Layer (ETL) and the cathode layer C. The layer may comprise lithium fluoride, cesium fluoride, silver, liq ((8-hydroxyquinoline) lithium), li ₂ O、BaF ₂ MgO and/or NaF.

Optionally, the Electron Transport Layer (ETL) and/or the Hole Blocking Layer (HBL) may also comprise one or more host materials.

As used herein, if not more specifically defined in a specific context, the designation of the color of emitted and/or absorbed light is as follows:

purple: wavelength range >380nm to 420 nm;

deep blue: wavelength range >420nm to 480 nm;

sky blue: wavelength range >480nm to 500 nm;

green: a wavelength range of >500nm to 560 nm;

yellow: wavelength range of >560nm to 580 nm;

orange: wavelength range of >580nm to 620 nm;

red: wavelength range of >620nm to 800 nm.

This color refers to the emission maximum of the main emission peak relative to the luminescent molecule (in other words: emitter molecule). Thus, illustratively, a deep blue emitter has an emission maximum in the range of >420nm to 480nm, a sky blue emitter has an emission maximum in the range of >480nm to 500nm, a green emitter has an emission maximum in the range of >500nm to 560nm, and a red emitter has an emission maximum in the range of >620nm to 800 nm.

The deep blue emitter may preferably have an emission maximum below 475nm (more preferably below 470nm, even more preferably below 465nm, or even below 460 nm). It will typically be above 420nm (preferably above 430nm, more preferably above 440nm, or even above 450 nm). In a preferred embodiment, the organic molecule according to the invention exhibits an emission maximum between 420nm and 500nm (more preferably between 430nm and 490nm, even more preferably between 440nm and 480nm, most preferably between 450nm and 470 nm), typically measured at room temperature (i.e. (approximately) 20 ℃) in poly (methyl methacrylate) (PMMA), mCBP with 0.001mg/mL of organic molecule according to the invention or alternatively in an organic solvent (preferably DCM or toluene) by a spin-coated film with 1 to 5 wt% (preferably 2 wt%) of organic molecule according to the invention.

Yet another embodiment relates to an OLED comprising at least one organic molecule according to the invention and emitting light having CIEx (=0.131) and CIEy (=0.046) color coordinates close to CIEx (=0.131) and CIEy (=0.046) color coordinates as primary colors blue (ciex=0.131 and ciey=0.046) as defined by ITU-r segmentation bt.2020 (rec.2020), and thus the OLED is suitable for use in Ultra High Definition (UHD) displays (e.g. UHD-TV). Thus, a further aspect of the invention relates to an OLED comprising at least one organic molecule according to the invention, the emission of which exhibits CIEx color coordinates between 0.02 and 0.30 (preferably between 0.03 and 0.25, more preferably between 0.05 and 0.20, or even more preferably between 0.08 and 0.18, or even between 0.10 and 0.15) and/or CIEy color coordinates between 0.00 and 0.45 (preferably between 0.01 and 0.30, more preferably between 0.02 and 0.20, or even more preferably between 0.03 and 0.15, or even between 0.04 and 0.10).

Yet another embodiment relates to an OLED comprising at least one organic molecule according to the present invention and being at 1000cd/m ² Exhibits an external quantum efficiency of greater than 8% (more preferably greater than 10%, more preferably greater than 13%, even more preferably greater than 15%, or even greater than 20%) and/or exhibits an emission maximum between 420nm and 500nm (more preferably between 430nm and 490nm, even more preferably between 440nm and 480nm, most preferably between 450nm and 470 nm), or still and/or between 500cd/m ² The following exhibits a LT80 value of greater than 100 hours (preferably greater than 200 hours, more preferably greater than 400 hours, even more preferably greater than 750 hours, or even greater than 1000 hours).

The green emitter material may preferably have an emission maximum between 500nm and 560nm (more preferably between 510nm and 550nm, even more preferably between 520nm and 540 nm).

A further preferred embodiment relates to an OLED comprising at least one organic molecule according to the invention and emitting light at different color points. Preferably, the OLED emits light having a narrow emission band (small Full Width Half Maximum (FWHM)). In a preferred embodiment, an OLED comprising at least one organic molecule according to the invention emits light with a FWHM having a main emission peak of less than 0.30 (preferably less than 0.25eV, more preferably less than 0.20eV, even more preferably less than 0.10eV, or even less than 0.17 eV).

According to the invention, an optoelectronic device comprising at least one organic molecule according to the invention may be used, for example, in a display, as a light source in lighting applications, and as a light source in medical and/or cosmetic applications (e.g. phototherapy).

Combinations of organic molecules according to the invention with other materials

Any layer, in particular the light emitting layer (EML), within an optoelectronic device, here preferably an OLED, may consist of a single material or a combination of different materials, which form part of the common general knowledge of a person skilled in the art.

For example, it is understood by those skilled in the art that the EML may be composed of a single material capable of emitting light when a voltage (and current) is applied to the device. However, it is also understood by those skilled in the art that the combination of different materials (in particular, one or more host materials (in other words: host materials; when included in an optoelectronic device comprising at least one organic molecule according to the invention, referred to herein as host material H) in the EML of the optoelectronic device (here preferably an OLED) ^B ) And one or more dopant materials, wherein at least one is emissive (i.e., an emitter material) upon application of voltage and current to the device) may be beneficial.

In a preferred embodiment of the use of the organic molecules according to the invention in an optoelectronic device, the optoelectronic device comprises at least one organic molecule according to the invention in the EML or in a layer directly adjacent to the EML or in more than one of these layers.

In a preferred embodiment of the use of the organic molecules according to the invention in an optoelectronic device, the optoelectronic device is an OLED and at least one organic molecule according to the invention is comprised in the EML or in a layer directly adjacent to the EML or in more than one of these layers.

In an even more preferred embodiment of the use of the organic molecule according to the invention in an optoelectronic device, the optoelectronic device is an OLED and at least one organic molecule according to the invention is comprised in an EML.

In one embodiment involving an optoelectronic device (preferably an OLED) comprising at least one organic molecule according to the invention, at least one (preferably each) organic molecule according to the invention is used as an emitter material in the light emitting layer EML, that is to say it emits light when a voltage (and current) is applied to the device.

As known to those skilled in the art, light emission from an emitter material (i.e., emissive dopant) in, for example, an Organic Light Emitting Diode (OLED) may include fluorescence from an excited singlet state (typically the lowest excited singlet state S1) and phosphorescence from an excited triplet state (typically the lowest excited triplet state T1).

The fluorescent emitter F is capable of emitting light at room temperature (i.e., (approximately) 20 ℃) upon excitation of electrons (e.g., in an optoelectronic device), wherein the emitted excited state is a singlet state. Fluorescent emitters typically exhibit instant (i.e., direct) fluorescence on a nanosecond time scale when initial electron excitation (e.g., by electron-hole recombination) provides an excited singlet state of the emitter.

In the context of the invention, a delayed fluorescent material is a material capable of reaching an excited triplet state (typically from the lowest excited triplet state T1) from an excited triplet state (typically from the lowest excited triplet state S1) by means of reverse intersystem crossing (RISC; in other words: upward intersystem crossing or reverse intersystem crossing) and also capable of emitting light upon returning from the excited triplet state thus reached (typically S1) to its electronic ground state. From the excited triplet state (typically T1) to after RISCFluorescence emission observed by emission excited singlet states (typically S1) occurs on a time scale (typically in the range of microseconds) that is slower than the time scale (typically in the range of nanoseconds) at which direct (i.e., instant) fluorescence occurs, and is therefore referred to as Delayed Fluorescence (DF). When RISC from an excited triplet state (typically from T1) to an excited singlet state (typically to S1) occurs by thermal activation, and if the excited singlet state thus filled emits light (delayed fluorescence emission), this process is called Thermally Activated Delayed Fluorescence (TADF). Thus, as described above, a TADF material is a material capable of emitting Thermally Activated Delayed Fluorescence (TADF). It is known to those skilled in the art that when the lowest excited singlet energy level E (S1 ^E ) And the lowest excited triplet level E (T1) ^E ) Energy difference ΔE between _ST When reduced, a population of the lowest excited triplet states can be generated from the lowest excited triplet states with high efficiency by means of RISC. Thus, TADF materials will typically have a small Δe _ST Values (see below) which form part of the common general knowledge of a person skilled in the art. As known to those skilled in the art, TADF materials may not be just materials that are themselves capable of RISC from an excited triplet state to an excited singlet state and subsequently emit TADF as described above. It is known to the person skilled in the art that the TADF material may in fact also be formed from two materials (preferably from two host materials H ^B More preferably from p host material H ^P And n host material H ^N ) The exciplex formed (see below).

The occurrence of (thermally activated) delayed fluorescence may be analyzed, for example, based on decay curves obtained from time-resolved (i.e., transient) Photoluminescence (PL) measurements. For this purpose, a spin-coated film of the corresponding emitter (i.e., a hypothetical TADF material) in poly (methyl methacrylate) (PMMA) with 1 to 10 wt% (specifically, 10 wt%) of the corresponding emitter can be used as a sample. Analysis can be performed, for example, using an FS5 fluorescence spectrometer from an Edinburgh instrument (Edinburgh instruments). The sample PMMA film can be placed in a cuvette and kept under a nitrogen atmosphere during measurement. Data acquisition may be performed using well-known time-dependent single photon counting (TCSPC, see below) techniques. In order to collect full decay kinetics over time and signal intensity of several orders of magnitude, measurements in four time windows (200 ns, 1 μs and 20 μs and longer measurements spanning >80 μs) can be made and combined (see below).

The TADF material preferably satisfies the following two conditions with respect to the above-described full decay kinetics:

(i) Decay kinetics exhibit two time regions, one in the nanosecond (ns) range and the other in the microsecond (μs) range; and is also provided with

(ii) The shape of the emission spectrum in the two time zones is consistent;

wherein part of the light emitted in the first attenuation zone is regarded as instant fluorescence and part of the light emitted in the second attenuation zone is regarded as delayed fluorescence.

The ratio of delayed fluorescence to instant fluorescence may be expressed in the form of a so-called n value, which can be calculated by integration of the corresponding photoluminescence decay over time according to the following equation:

in the context of the present invention, TADF materials preferably exhibit n values (ratio of delayed fluorescence to instant fluorescence) of greater than 0.05 (n > 0.05), more preferably greater than 0.1 (n > 0.1), even more preferably greater than 0.15 (n > 0.15), particularly preferably greater than 0.2 (n > 0.20), or even greater than 0.25 (n > 0.25).

In a preferred embodiment, the organic molecule according to the invention exhibits an n-value (ratio of delayed fluorescence to instant fluorescence) of more than 0.05 (n > 0.05).

In the context of the present invention, TADF Material E ^B Characterized by exhibiting a delta E of less than 0.4eV (preferably less than 0.3eV, more preferably less than 0.2eV, even more preferably less than 0.1eV, or even less than 0.05 eV) _ST Value, deltaE _ST The value corresponds to the lowest excited singlet energy level E (S1 ^E ) And the lowest excited triplet level E (T1) ^E ) Energy difference between them. Determination of TADF MaterialMaterial E ^B Delta E of (2) _ST The method of values is given in the subsections later herein.

One approach for designing TADF materials is generally to covalently attach one or more (electron) donor moieties with HOMO distributed thereon and one or more (electron) acceptor moieties with LUMO distributed thereon to the same bridge, referred to herein as a linking group. TADF Material E ^B Two or three linking groups may be included, for example, that are bound to the same acceptor moiety, and additional donor and acceptor moieties may be bound to each of the two or three linking groups.

One or more donor moieties and one or more acceptor moieties may also be directly bound to each other (in the absence of a linking group).

Typical donor moieties are diphenylamines, indoles, carbazoles, acridines, phenoxazines and derivatives of related structures. In particular, an alicyclic, aromatic or heteroaromatic ring system may be fused to the donor motif described above to give, for example, indolocarbazoles.

Benzene derivatives, biphenyl derivatives and to some extent also terphenyl derivatives are common linking groups.

Nitrile groups are common acceptor moieties in TADF materials, known examples of which include:

(i) Carbazolyl dicyanobenzene compounds

Such as 2CzPN (4, 5-bis (9H-carbazol-9-yl) phthalonitrile), DCzIPN (4, 6-bis (9H-carbazol-9-yl) isophthalonitrile), 4CzPN (3, 4,5, 6-tetrakis (9H-carbazol-9-yl) phthalonitrile), 4CzIPN (2, 4,5, 6-tetrakis (9H-carbazol-9-yl) isophthalonitrile), 4CzTPN (2, 4,5, 6-tetrakis (9H-carbazol-9-yl) terephthalonitrile) and derivatives thereof;

(ii) Carbazolyl cyanopyridine compounds

Such as 4CzCNPy (2, 3,5, 6-tetrakis (9H-carbazol-9-yl) -4-cyanopyridine) and derivatives thereof;

(iii) Carbazolyl cyanobiphenyl compounds

Such as CNBPCz (4, 4', 5' -tetra (9H-carbazol-9-yl) - [1,1' -biphenyl ] -2,2' -dinitrile), czBPCN (4, 4', 6' -tetra (9H-carbazol-9-yl) - [1,1' -biphenyl ] -3,3' -dinitrile), DDCzIPN (3, 3', 5' -tetra (9H-carbazol-9-yl) - [1,1' -biphenyl ] -2,2', 6' -tetramethylnitrile) and derivatives thereof;

wherein, in these materials, one or more of the nitrile groups may be treated as acceptor moiety by fluorine (F) or trifluoromethyl (CF) ₃ ) Instead of.

Nitrogen heterocycles such as triazine derivatives, pyrimidine derivatives, triazole derivatives, oxadiazole derivatives, thiadiazole derivatives, heptazine derivatives, 1, 4-diazabenzo [9,10] phenanthrene derivatives, benzothiazole derivatives, benzoxazole derivatives, quinoxaline derivatives and diazafluorene derivatives are also well known acceptor moieties for use in constructing TADF materials. Known examples of TADF materials including, for example, triazine receptors include PIC-TRZ (7, 7' - (6- ([ 1,1' -biphenyl ] -4-yl) -1,3, 5-triazine-2, 4-diyl) bis (5-phenyl-5, 7-indolino [2,3-b ] carbazole)), mBFCzTrz (5- (3- (4, 6-diphenyl-1, 3, 5-triazin-2-yl) phenyl) -5H-benzofuro [3,2-c ] carbazole) and DCzTrz (9, 9' - (5- (4, 6-diphenyl-1, 3, 5-triazin-2-yl) -1, 3-phenylene) bis (9H-carbazole)).

Another group of TADF materials includes diaryl ketones such as benzophenone or (heteroaryl) aryl ketones such as 4-benzoylpyridine, 9, 10-anthraquinone, 9H-xanthen-9-one and derivatives thereof as acceptor moieties to which the donor moiety (typically of carbazolyl substituents) is bound. Examples of such TADF materials include BPBCz (bis (4- (9 ' -phenyl-9H, 9' H- [3,3' -dicarbazol ] -9-yl) phenyl) methanone), mDCBP ((3, 5-bis (9H-carbazol-9-yl) phenyl) (pyridin-4-yl) methanone), AQ-DTBu-Cz (2, 6-bis (4- (3, 6-di-tert-butyl-9H-carbazol-9-yl) phenyl) anthracene-9, 10-dione) and MCz-XT (3- (1, 3,6, 8-tetramethyl-9H-carbazol-9-yl) -9H-xanthen-9-one), respectively.

Sulfoxides (specifically diphenyl sulfoxide) are also commonly used as acceptor moieties for constructing TADF materials, and known examples include 4-PC-DPS (9-phenyl-3- (4- (phenylsulfonyl) phenyl) -9H-carbazole), ditBu-DPS (9, 9' - (sulfonylbis (4, 1-phenylene)) bis (9H-carbazole)) and TXO-PhCz (2- (9-phenyl-9H-carbazol-3-yl) -9H-thioxanthen-9-one 10, 10-dioxide).

It is understood that the fluorescent emitter F may also exhibit a fluorescence as defined hereinTADF and even TADF material E as defined herein ^B . Thus, a small FWHM emitter S as defined herein ^B May or may not be TADF material E as defined herein ^B 。

Phosphorescence (i.e., light emission from an excited triplet state, typically from the lowest excited triplet state T1) is a spin-forbidden process. As known to those skilled in the art, phosphorescence may be promoted (enhanced) by exploiting (intramolecular) spin-orbit interactions, the so-called (internal) heavy atom effect. Phosphorescent material P in the context of the invention ^B Is a phosphorescent emitter capable of emitting phosphorescence at room temperature (i.e., at approximately 20 ℃).

Here, it is preferable that the phosphorescent material P ^B At least one atom including an element having a standard atomic weight larger than that of calcium (Ca). Even more preferably, the phosphorescent material P in the context of the invention ^B Comprising transition metal atoms (specifically, transition metal atoms of elements having a standard atomic weight larger than that of zinc (Zn)). Preferably included in the phosphorescent material P ^B The transition metal atoms of (a) may be present in any oxidation state (and may also be present as ions of the corresponding element).

As is well known to those skilled in the art, phosphorescent materials P are used in optoelectronic devices ^B Typically a complex of Ir, pd, pt, au, os, eu, ru, re, ag and Cu (preferably Ir, pt and Pd, more preferably Ir and Pt in the context of the present invention). Those skilled in the art know which materials are suitable as phosphorescent materials P in optoelectronic devices ^B And how to synthesize them. Furthermore, the person skilled in the art is familiar with the design principles of phosphorescent complexes for use as phosphorescent materials in optoelectronic devices and knows how to adjust the emission of the complex by means of structural changes.

Those skilled in the art know which materials are suitable as phosphorescent materials P for use in optoelectronic devices ^B And how to synthesize them. In this respect, those skilled in the art are particularly familiar with phosphorescent materials P for use in optoelectronic devices ^B Is known and the design principle of the phosphorescent complex of (2)How to adjust the emission of the complex by means of structural changes.

Phosphorescent materials P which can be used together with the organic molecules according to the invention are disclosed in the prior art ^B For example, in the form of a composition or in the EML of an optoelectronic device, see below). For example, the following metal complexes are phosphorescent materials P which can be used together with the organic molecules according to the invention ^B ：

Small Full Width Half Maximum (FWHM) emitter S in the context of the invention ^B Is any emitter (i.e., emitter material) having an emission spectrum that exhibits a FWHM of less than or equal to 0.35eV (0.35 eV or less), preferably less than or equal to 0.30eV (0.30 eV or less), specifically less than or equal to 0.25eV (0.25 eV or less). Unless otherwise indicated, this is judged based on the emission spectrum of the corresponding emitter at room temperature (i.e., (approximately) 20 ℃) and is typically measured with 1 to 5 wt% (specifically, 2 wt%) emitter in poly (methyl methacrylate) (PMMA) or mCBP. Alternatively, a small FWHM emitter S ^B The emission spectrum of (a) can be measured in solution, typically with 0.001mg/mL to 0.2mg/mL of emitter S in methylene chloride or toluene at room temperature (i.e., (approximately) 20 ℃) ^B 。

Small FWHM emitter S ^B May be a fluorescent emitter F, a phosphorescent emitter (e.g., phosphorescent material P ^B ) And/or TADF emitters (e.g., TADF material E ^B ). For TADF Material E as described above ^B And for phosphorescent material P ^B By reacting at room temperature (i.e., approximately 20 ℃) the corresponding molecule E of the invention with 10% by weight ^B Or P ^B The spin-coated film of the corresponding material in poly (methyl methacrylate) (PMMA) records the emission spectrum.

As known to those skilled in the art, emitters (e.g., small FWHM emitters S ^B ) Is easy to pass through the corresponding emission spectrum (for fluorescent emitters)Fluorescence spectrum and phosphorescence spectrum for phosphorescent emitters). All reported FWHM values are generally referred to as the main emission peak (i.e., the peak with the highest intensity). The manner in which the FWHM (preferably reported here in electron volts eV) is determined is part of the knowledge of the person skilled in the art. For example, assume that the main emission peak of the emission spectrum is at two wavelengths λ ₁ And lambda (lambda) ₂ At which half maximum emission (i.e. 50% of maximum emission intensity) is reached (the two wavelengths lambda ₁ And lambda (lambda) ₂ Both are obtained in nanometers (nm) by emission spectroscopy, and the FWHM in electron volts (eV) is typically (and here) determined using the following equation:

in the context of the invention, a small FWHM emitter S ^B Is an organic emitter, which in the context of the invention means that it does not contain any transition metal. Preferably, a small FWHM emitter S in the context of the invention ^B Mainly composed of the elements hydrogen (H), carbon (C), nitrogen (N) and boron (B), but may also include, for example, oxygen (O), silicon (Si), fluorine (F) and bromine (Br).

Furthermore, it is preferred that in the context of the invention a small FWHM emitter S ^B Is a fluorescent emitter F that may or may not additionally exhibit TADF.

Preferably, a small FWHM emitter S in the context of the invention ^B Preferably at least one of the following requirements is fulfilled:

(i) It is a boron (B) containing emitter, which means a correspondingly small FWHM emitter S ^B At least one atom in the ring is boron (B);

(ii) It includes a polycyclic aromatic or heteroaromatic core structure in which at least two aromatic rings are fused together (e.g., anthracene, pyrene, or aza derivatives thereof).

As known to those skilled in the art, host material H of EML ^B Electrons or positive charges can be transported through the EML and excitation energy can also be transferred to the host material H ^B At least one emitter material of (a). In the artThose skilled in the art understand that host material H included in the EML of an optoelectronic device (e.g., OLED) ^B Typically do not significantly participate in light emission from the device upon application of voltage and current. The person skilled in the art is also familiar with the following facts: any host material H ^B May be p-host H exhibiting high hole mobility ^P N-host H exhibiting high electron mobility ^N Or a bipolar host material H exhibiting both high hole mobility and high electron mobility ^BP 。

As known to those skilled in the art, EML may also include a cell having at least one p-body H ^P And an n-body H ^N Is described in the following. In particular, the EML may comprise exactly one emitter material according to the invention and a mixed host system comprising as n host H ^N T2T (2, 4, 6-tris (biphenyl-3-yl) -1,3, 5-triazine) as p-mer H ^P Is selected from CBP, mCP, mCBP, 4, 6-diphenyl-2- (3- (triphenylsilyl) phenyl) -1,3, 5-triazine, 9- [3- (dibenzofuran-2-yl) phenyl]-9H-carbazole, 9- [3- (dibenzothiophen-2-yl) phenyl ]]-9H-carbazole, 9- [3, 5-bis (2-dibenzofuranyl) phenyl ]]-9H-carbazole and 9- [3, 5-bis (2-dibenzothienyl) phenyl ] ]-a host of 9H-carbazole.

The EML may include a cell having at least one p-body H ^P And an n-body H ^N Is a so-called hybrid host system; wherein n is a main body H ^N Comprising groups derived from pyridine, pyrimidine, benzopyrimidine, 1,3, 5-triazine, 1,2, 4-triazine and 1,2, 3-triazine, and p-mer H ^P Including groups derived from indoles, isoindoles and preferably carbazoles.

Those skilled in the art know which materials are suitable host materials for use in optoelectronic devices. It is understood that any host material used in the prior art may be a suitable host material H in the context of the invention ^B 。

As p-host material H in the context of the invention ^P Material H of (2) ^B Examples of (a) are listed below:

/>

as n host material H in the context of the invention ^N Material H of (2) ^B Examples of (a) are listed below:

/>

those skilled in the art will appreciate that any materials included in the same layer (in particular, in the same EML) and in close proximity in adjacent layers and at the interface between these adjacent layers may together form an exciplex. Those skilled in the art know how to select pairs of exciplex forming materials (in particular, p-host H ^P And n main body H ^N Pair) and selection criteria (including HOMO and/or LUMO energy level requirements) for both components of the material pair. That is, where exciplex formation can be desired, one component (e.g., p-host material H ^P ) The Highest Occupied Molecular Orbital (HOMO) of (a) may be energetically higher than that of another component (e.g., n host material H ^N ) Has a HOMO at least 0.20eV high, and one component (e.g., p-host material H ^P ) The Lowest Unoccupied Molecular Orbital (LUMO) of (a) may be energetically higher than another component (e.g., n host material H ^N ) Is at least 0.20eV higher. It is common knowledge of the person skilled in the art that an exciplex can be present in the EML of an optoelectronic device (in particular, an OLED) if the exciplex is presentTo have the function of an emitter material and to emit light when a voltage and current are applied to the device. As is also known by the prior art, exciplex may also be non-emissive and, if included in the EML of an optoelectronic device, may transfer excitation energy to the emitter material, for example.

As known to those skilled in the art, triplet-triplet annihilation (TTA) materials can be used as host material H ^B . TTA materials are capable of triplet-triplet annihilation. Triplet-triplet annihilation can preferably cause photon up-conversion. Thus, two, three or even more photons can contribute to the light flux from TTA material H ^TTA The lowest excited triplet state (T1) ^TTA ) To a first excited singlet S1 ^TTA Photon up-conversion of (a). In a preferred embodiment, two photons are promoted from T1 ^TTA To S1 ^TTA Photon up-conversion of (a). Thus, triplet-triplet annihilation can be a process that involves many energy transfer steps, and two (or alternatively more than two) low frequency photons can be combined into one photon of higher frequency.

Alternatively, the TTA material can include an absorbing portion, a sensitizer portion, and an emitting portion (or annihilator portion). In this context, the emitting moiety may be, for example, a polycyclic aromatic moiety (such as benzene, biphenyl, terphenyl, benzo [9,10 ]]Phenanthrene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,Perylene and azulene). In a preferred embodiment, the polycyclic aromatic moiety comprises an anthracene moiety or derivative thereof. The sensitizer moiety and the emissive moiety may be located in two different chemical compounds (i.e., separate chemical entities), or may be two moieties contained by one chemical compound.

According to the invention, a triplet-triplet annihilation (TTA) material transfers energy from the first excited triplet state T1 by triplet-triplet annihilation ^N Transition to the first excited singlet S1 ^N 。

According to the invention, the TTA material is characterized in that it is derived from the lowest excited triplet state (T1 ^N ) Exhibits triplet-triplet annihilation, resulting in a first excited singlet S1 of triplet-triplet annihilation ^N With up to T1 ^N Twice the energy of (2).

In one embodiment of the invention, the TTA material is characterized in that it exhibits T1 ^N Triplet-triplet annihilation of (2) leading to S1 ^N ，S1 ^N With T1 ^N 1.01 to 2 times, 1.1 to 1.9 times, 1.2 to 1.5 times, 1.4 to 1.6 times, or 1.5 to 2 times the energy of (c).

As used herein, the terms "TTA material" and "TTA compound" are interchangeably understood.

"TTA materials" are commonly found in the prior art in connection with blue fluorescent OLEDs, as described by Kondakov (Philosophical Transactions of the Royal Society A: mathematical, physical and Engineering Sciences, 2015, 373:20140321). Such blue fluorescent OLED employs aromatic hydrocarbons such as anthracene derivatives as a main component (host) in the EML.

In a preferred embodiment, the TTA material is capable of sensitizing triplet-triplet annihilation. Alternatively, the TTA material may include one or more polycyclic aromatic structures. In a preferred embodiment, the TTA material includes at least one polycyclic aromatic structure and at least one other aromatic residue.

In a preferred embodiment, the TTA material has a greater singlet-triplet energy split, i.e., its first excited singlet S1 ^N With its lowest excited triplet state T1 ^N The energy difference between them is at least 1.1 times, at least 1.2 times, at least 1.3 times, at least 1.5 times, preferably not more than 2 times.

In a preferred embodiment of the invention, TTA Material H ^TTA Is an anthracene derivative.

In one embodiment, TTA material H ^TTA Is an anthracene derivative of the following formula 4:

wherein,

each Ar is independently selected from the group consisting of: c (C) ₆ -C ₆₀ Aryl optionally substituted with a member selected from the group consisting of C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups; c ₃ -C ₅₇ Heteroaryl optionally substituted with a member selected from C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups; and is also provided with

Each A ₁ Independently of each other selected from the group consisting of: hydrogen; deuterium; c (C) ₆ -C ₆₀ Aryl optionally substituted with a member selected from the group consisting of C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups; c (C) ₃ -C ₅₇ Heteroaryl optionally substituted with a member selected from C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups; c ₁ -C ₄₀ (hetero) alkyl optionally substituted with a member selected from the group consisting of C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups.

In one embodiment, TTA material H ^TTA Is an anthracene derivative of formula 4, wherein,

each Ar is independently selected from the group consisting of: c (C) ₆ -C ₂₀ Aryl optionally substituted with a member selected from the group consisting of C ₆ -C ₂₀ Aryl, C ₃ -C ₂₀ Heteroaryl, halogen and C ₁ -C ₁₀ One or more residues of the group consisting of (hetero) alkyl groups; c ₃ -C ₂₀ Heteroaryl optionally substituted with a member selected from C ₆ -C ₂₀ Aryl, C ₃ -C ₂₀ Heteroaryl, halogen and C ₁ -C ₁₀ One or more residues of the group consisting of (hetero) alkyl groups; and is also provided with

Each A ₁ Independently of each other selected from the group consisting of: hydrogen; deuterium; c (C) ₆ -C ₂₀ Aryl optionally substituted with a member selected from the group consisting of C ₆ -C ₂₀ Aryl, C ₃ -C ₂₀ Heteroaryl, halogen and C ₁ -C ₁₀ One or more residues of the group consisting of (hetero) alkyl groups; c (C) ₃ -C ₂₀ Heteroaryl optionally substituted with a member selected from C ₆ -C ₂₀ Aryl, C ₃ -C ₂₀ Heteroaryl, halogen and C ₁ -C ₁₀ One or more residues of the group consisting of (hetero) alkyl groups; c ₁ -C ₁₀ (hetero) alkyl optionally substituted with a member selected from the group consisting of C ₆ -C ₂₀ Aryl, C ₃ -C ₂₀ Heteroaryl, halogen and C ₁ -C ₁₀ One or more residues of the group consisting of (hetero) alkyl groups.

In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein A ₁ At least one of which is hydrogen. In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein A ₁ At least two of which are hydrogen. In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein A ₁ At least three of which are hydrogen. In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein A ₁ All of which are hydrogen.

In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein one of Ar is selected from the group consisting of phenyl, naphthyl, phenanthryl, pyrenyl, benzo [9,10 ]]Phenanthryl, dibenzanthracene, fluorenyl, benzofluorenyl, anthracenyl, benzonaphthofuranyl, benzonaphthothienyl, dibenzofuranyl, and dibenzothienyl,

the above groups may be optionally substituted with a member selected from the group consisting of C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups.

In one embodiment, H ^TTA Is an anthracene derivative of formula 4, wherein two Ar are each independently selected from the group consisting of phenyl, naphthyl, phenanthryl, pyrenyl, benzo [9,10 ]]Phenanthryl, dibenzanthracene, fluorenyl, benzofluorenyl, anthracenyl, benzonaphthofuranyl, benzonaphthothienyl, dibenzofuranyl, and dibenzothienyl,

In one embodiment, TTA material H ^TTA Is an anthracene derivative selected from the group consisting of:

/>

composition comprising at least one organic molecule according to the invention

One aspect of the invention relates to a composition comprising at least one organic molecule according to the invention. One aspect of the invention relates to the use of the composition in an optoelectronic device (preferably an OLED), in particular in the EML of said device.

In the following, when describing the above-mentioned compositions, reference is made in some cases to the content of certain materials in the respective compositions in the form of percentages. It will be noted that unless otherwise specified for a particular embodiment, all percentages refer to weight percentages which have the same meaning as weight percentages or wt% ((weight/weight), (w/w), wt%). It is understood that when, for example, the content of one or more organic molecules according to the invention in a particular composition is illustrated as being exemplary 30%, this means that the total weight of one or more organic molecules according to the invention (i.e. all of these molecular combinations) is 30% by weight, i.e. 30% of the total weight of the corresponding composition. It is understood that the total content of all components adds up to 100% by weight (i.e., the total weight of the composition) whenever the composition is specified by providing the preferred content of its components in% by weight.

When the following description refers to embodiments of the invention involving compositions comprising at least one organic molecule according to the invention, reference will be made to energy transfer processes that can occur between components within these compositions when the compositions are used in an optoelectronic device, preferably in an EML of an optoelectronic device, most preferably in an EML of an OLED. It is understood by those skilled in the art that such an excitation energy transfer process may enhance emission efficiency when the composition is used in the EML of an optoelectronic device.

When describing a composition comprising at least one organic molecule according to the invention, it will also be pointed out that certain materials are "different" from other materials. This means that the materials "different" from each other do not have the same chemical structure.

In one embodiment, the composition comprises or consists of the following components:

(a) One or more organic molecules according to the invention; and

(b) One or more host materials H which are different from the organic molecules of (a) ^B The method comprises the steps of carrying out a first treatment on the surface of the And

(c) Optionally, one or more dyes and/or solvents.

(a) One or more organic molecules according to the invention; and

(b) One or more host materials H which are different from the organic molecules of (a) ^B ，

Wherein the host material H in the composition ^B The fraction in% by weight of (c) is higher than the fraction in% by weight of the organic molecules according to the invention, preferably the host material H in the composition ^B The fraction in weight% of (c) is greater than twice the fraction in weight% of the organic molecule according to the invention.

(a) 0.1 to 30 wt.% (preferably 0.8 to 15 wt.%, in particular 1.5 to 5 wt.%) of an organic molecule according to the invention; and

(b) As a host material H according to the following formula 4 ^B Is a TTA material of (C):

(a) An organic molecule according to the invention; and

(b) Host material H different from the organic molecule of (a) ^B ；

(c) TADF Material E ^B And/or phosphorescent material P ^B 。

(a) 0.1 to 20 wt.% (preferably 0.5 to 12 wt.%, in particular 1 to 5 wt.%) of an organic molecule according to the invention; and

(b) 0 to 98.8% by weight (preferably 35 to 94% by weight, in particular 60 to 88% by weight) of aA host material H of one or more species different from the organic molecule according to the invention ^B The method comprises the steps of carrying out a first treatment on the surface of the And

(c) 0.1 to 20 wt.% (preferably 0.5 to 10 wt.%, in particular 1 to 3 wt.%) of one or more phosphorescent materials P which are different from the organic molecules of (a) ^B The method comprises the steps of carrying out a first treatment on the surface of the And

(d) 1 to 99.8 wt% (preferably 5 to 50 wt%, in particular 10 to 30 wt%) of one or more TADF materials E different from the organic molecules of (a) ^B The method comprises the steps of carrying out a first treatment on the surface of the And

(e) 0 to 98.8 wt% (preferably 0 to 59 wt%, in particular 0 to 28 wt%) of one or more solvents.

In a further aspect, the invention relates to an optoelectronic device comprising an organic molecule or composition of the type described herein, more particularly in the form of a device selected from the group consisting of an Organic Light Emitting Diode (OLED), a light emitting electrochemical cell, an OLED sensor (more particularly a gas and vapor sensor that is not hermetically isolated from the outside), an organic diode, an organic solar cell, an organic transistor, an organic field effect transistor, an organic laser and a down conversion element.

In a preferred embodiment, the optoelectronic device is a device selected from the group consisting of an Organic Light Emitting Diode (OLED), a light emitting electrochemical cell (LEC) and a light emitting transistor.

In one embodiment of the inventive optoelectronic device, the organic molecules E according to the invention are used as emissive material in the light emitting layer EML.

In one embodiment of the inventive optoelectronic device, the light emitting layer EML consists of the composition according to the invention described herein.

When the optoelectronic device is an OLED, it may for example have the following layer structure:

1. substrate

2. Anode layer, A

3. Hole injection layer, HIL

4. Hole transport layer, HTL

5. Electron blocking layer, EBL

6. Emissive layer, EML

7. Hole blocking layer, HBL

8. Electron transport layer, ETL

9. Electron injection layer, EIL

10. A cathode layer, C,

wherein the OLED comprises each layer selected from the group of HIL, HTL, EBL, HBL, ETL and EIL, only optionally different layers may be combined, the OLED may comprise more than one layer of each layer type as defined above.

Furthermore, in one embodiment, the optoelectronic device may include one or more protective layers that protect the device from damaging exposure to harmful substances in the environment, including, for example, moisture, steam, and/or gases.

In one embodiment of the invention, the optoelectronic device is an OLED having the following inverted layer structure:

1. substrate

2. Cathode layer, C

3. Electron injection layer, EIL

4. Electron transport layer, ETL

5. Hole blocking layer, HBL

6. Emissive layer, EML

7. Electron blocking layer, EBL

8. Hole transport layer, HTL

9. Hole injection layer, HIL

10. The anode layer, a,

In one embodiment of the invention, the optoelectronic device is an OLED that may have a stacked structure. In this configuration, the individual cells are stacked on top of each other, contrary to typical arrangements in which the OLEDs are placed side by side. The mixed light may be generated with the OLED exhibiting a stacked structure, and in particular, the white light may be generated by stacking the blue OLED, the green OLED, and the red OLED. Furthermore, an OLED exhibiting a stacked structure may comprise a Charge Generating Layer (CGL), typically positioned between two OLED subunits and typically consisting of an n-doped layer and a p-doped layer and an n-doped layer of one CGL typically positioned close to the anode layer.

In one embodiment of the invention, the optoelectronic device is an OLED comprising two or more emissive layers between an anode and a cathode. In particular, such a so-called tandem OLED comprises three emission layers, of which one emits red light, one emits green light, one emits blue light, and optionally further layers such as charge generating layers, blocking layers or transport layers may be included between the respective emission layers. In yet another embodiment, the emissive layers are stacked adjacently. In yet another embodiment, the tandem OLED includes a charge generating layer between each two emissive layers. In addition, adjacent emissive layers or emissive layers separated by a charge generating layer may be combined.

The substrate may be formed of any material or combination of materials. Most commonly, glass slides are used as substrates. Alternatively, a thin metal layer (e.g., copper, gold, silver, or aluminum film) or a plastic film or slide may be used. This may allow a higher degree of flexibility. The anode layer a is mainly composed of a material that allows to obtain a (substantially) transparent film. Since at least one of the two electrodes should be (substantially) transparent to allow light emission from the OLED, the anode layer a or the cathode layer C is transparent. Preferably, the anode layer a comprises, or even consists of, a large amount of Transparent Conductive Oxide (TCO). Such an anode layer a may for example comprise indium tin oxide, aluminum zinc oxide, fluorine doped tin oxide, indium zinc oxide, pbO, snO, zirconium oxide, molybdenum oxide, vanadium oxide, tungsten oxide, graphite, doped Si, doped Ge, doped GaAs, doped polyaniline, doped polypyrrole and/or doped polythiophene.

Anode layer a may be (substantially) made of Indium Tin Oxide (ITO) (e.g., (InO) ₃ ) _0.9 (SnO ₂ ) _0.1 ) Composition is prepared. Compensation for conducting by Transparent Conductive Oxide (TCO) by using Hole Injection Layer (HIL)Roughness of the anode layer a. Furthermore, because transport of quasi-charge carriers from the TCO to the Hole Transport Layer (HTL) is facilitated, the HIL may facilitate injection of quasi-charge carriers (i.e., holes). The Hole Injection Layer (HIL) may comprise poly (3, 4-ethylenedioxythiophene) (PEDOT), polystyrene sulfonate (PSS), moO ₂ 、V ₂ O ₅ CuPC or CuI (specifically, a mixture of PEDOT and PSS). The Hole Injection Layer (HIL) may also prevent diffusion of metal from the anode layer a into the Hole Transport Layer (HTL). The HIL may include, for example, PEDOT: PSS (poly (3, 4-ethylenedioxythiophene): polystyrene sulfonate), PEDOT (poly (3, 4-ethylenedioxythiophene)), mM DATA (4, 4' -tris [ phenyl (m-tolyl) amino)]Triphenylamine), spiro-TAD (2, 2', 7' -tetrakis (N, N-diphenylamino) -9,9' -spirobifluorene), DNTPD (N1, N1' - (biphenyl-4, 4' -diyl) bis (N1-phenyl-N4, N4-di-m-tolylphenyl-1, 4-diamine)), NPB (N, N ' -bis (1-naphthyl) -N, N ' -bis-phenyl (1, 1' -biphenyl) -4,4' -diamine), npnpnpb (N, N ' -diphenyl-N, N ' -bis [4- (N, N-diphenyl-amino) phenyl ]Benzidine), meO-TPD (N, N '-tetrakis (4-methoxyphenyl) benzidine), HAT-CN (1, 4,5,8,9, 12-hexaazabenzophenanthrene hexacarbonitrile) and/or spiro-NPD (N, N' -diphenyl-N, N '-bis (1-naphthyl) -9,9' -spirobifluorene-2, 7-diamine).

Adjacent to the anode layer a or the Hole Injection Layer (HIL), a Hole Transport Layer (HTL) is typically positioned. Any hole transport compound may be used herein. For example, electron-rich heteroaromatic compounds such as triarylamines and/or carbazole may be used as hole transport compounds. The HTL may reduce an energy barrier between the anode layer a and the emission layer EML. The Hole Transport Layer (HTL) may also be an Electron Blocking Layer (EBL). Preferably, the hole transporting compound has a relatively high energy level of its triplet T1. For example, the Hole Transport Layer (HTL) may include a material such as tris (4-carbazol-9-ylphenyl) amine (TCTA), poly-TPD (poly (4-butylphenyl-diphenyl-amine)), α -NPD (N, N '-bis (naphthalen-1-yl) -N, N' -bis (phenyl) -2,2 '-dimethylbenzidine), TAPC (4, 4' -cyclohexyl-bis [ N, N-bis (4-methylphenyl) aniline)]) 2-TNATA (4, 4' -tris [ 2-naphthyl (phenyl) amino)]Triphenylamine), spiro-TAD, DNTPD, NPB, NPNPB, meO-TPD, HAT-CN and/or Tris-Pcz (9, 9' -diphenyl-6- (9-phenyl-9H-carbazol-3-yl) -9H,9' H-3,3' -dicarbazole) A heterocyclic ring. In addition, the HTL may include a p-doped layer that may be composed of an inorganic dopant or an organic dopant in an organic hole transport matrix. Transition metal oxides such as vanadium oxide, molybdenum oxide or tungsten oxide may be used, for example, as inorganic dopants. Tetrafluorotetracyanoquinodimethane (F) ₄ TCNQ), copper pentafluorobenzoate (Cu (I) pFBz) or transition metal complexes may be used, for example, as organic dopants.

EBL may include, for example, mCP (1, 3-bis (carbazol-9-yl) benzene), TCTA, 2-TNATA, mCBP (3, 3-bis (9H-carbazol-9-yl) biphenyl), tris-Pcz, czSi (9- (4-tert-butylphenyl) -3, 6-bis (triphenylsilyl) -9H-carbazole) and/or DCB (N, N' -dicarbazolyl-1, 4-dimethylbenzene).

Adjacent to the Hole Transport Layer (HTL), an emission layer EML is typically positioned. The light emitting layer EML includes at least one organic molecule. In particular, the EML comprises at least one organic molecule E according to the invention. In one embodiment, the light emitting layer comprises only organic molecules according to the invention. Typically, the EML additionally comprises one or more host materials H. For example, the host material H is selected from CBP (4, 4' -bis (N-carbazolyl) biphenyl), mCP, mCBP, sif87 (dibenzo [ b, d ] thiophen-2-yl triphenylsilane), czSi, sif88 (dibenzo [ b, d ] thiophen-2-yl diphenylsilane), DPEPO (bis [2- (diphenylphosphino) phenyl ] ether oxide), 9- [3- (dibenzofuran) -2-yl) phenyl ] -9H-carbazole, 9- [3- (dibenzothiophen-2-yl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzofuranyl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzothiophenyl) phenyl ] -9H-carbazole, T2T (2, 4, 6-tris (biphenyl-3-yl) -1,3, 5-triazine), T3T (2, 4, 6-tris (terphenyl-3-yl) -1,3, 5-triazine) and/or TST (2, 4, 6-tris (terphenyl-3-yl) -1,3, 5-triazine). The host material H should typically be selected to exhibit a first triplet (T1) energy level and a first singlet (S1) energy level that are energetically higher than the first triplet (T1) energy level and the first singlet (S1) energy level of the organic molecule.

In one embodiment of the invention, the EML comprises a so-called hybrid host system with at least one hole-dominant host and one electron-dominant host. In a specific embodiment, the EML comprises exactly one organic molecule according to the invention and a mixed host system comprising T2T as electron-dominant host and a host selected from CBP, mCP, mCBP, 9- [3- (dibenzofuran-2-yl) phenyl ] -9H-carbazole, 9- [3- (dibenzothiophen-2-yl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzofuranyl) phenyl ] -9H-carbazole and 9- [3, 5-bis (2-dibenzothiophenyl) phenyl ] -9H-carbazole as hole-dominant host. In yet another embodiment, the EML comprises 50 to 80 wt% (preferably, 60 to 75 wt%) of a host selected from CBP, mCP, mCBP, 9- [3- (dibenzofuran-2-yl) phenyl ] -9H-carbazole, 9- [3- (dibenzothiophene-2-yl) phenyl ] -9H-carbazole, 9- [3, 5-bis (2-dibenzofuran-yl) phenyl ] -9H-carbazole, and 9- [3, 5-bis (2-dibenzothiophene) phenyl ] -9H-carbazole, 10 to 45 wt% (preferably, 15 to 30 wt%) T2T, and 5 to 40 wt% (preferably, 10 to 30 wt%) of an organic molecule according to the invention.

Adjacent to the emission layer EML, an Electron Transport Layer (ETL) may be positioned. Any electron transport body may be used herein. For example, electron-poor compounds such as benzimidazole, pyridine, triazole, oxadiazole (e.g., 1,3, 4-oxadiazole), phosphine oxide, and sulfone may be used. The electron transporter may also be, for example, 1,3, 5-tris (1-phenyl-1H-benzo [ d ]]Imidazol-2-yl) benzene (TPBi). ETL may include NBphen (2, 9-bis (naphthalen-2-yl) -4, 7-diphenyl-1, 10-phenanthroline), alq ₃ (tris (8-hydroxyquinoline) aluminum), TSPO1 (diphenyl-4-triphenylsilylphenyl-phosphine oxide), BPyTP2 (2, 7-bis (2, 2' -bipyridin-5-yl) benzo [9, 10)]Phenanthrene), sif87 (dibenzo [ b, d)]Thiophen-2-yl-triphenylsilane), sif88 (dibenzo [ b, d]Thiophen-2-yldiphenylsilane), bmPyPhB (1, 3-bis [3, 5-di (pyridin-3-yl) phenyl)]Benzene) and/or BTB (4, 4' -bis [2- (4, 6-diphenyl-1, 3, 5-triazinyl)]-1,1' -biphenyl). Alternatively, the ETL may be doped with a material such as Liq. The Electron Transport Layer (ETL) may also block holes or incorporate a Hole Blocking Layer (HBL).

The HBL may include, for example, BCP (2, 9-dimethyl-4, 7-diphenyl-1, 10-phenanthroline = bathocuproine), BAlq (bis (8-hydroxy-2-methylquinoline) - (4-phenylphenoxy) aluminum), NBphen (2, 9-bis (naphthalen-2-yl) -4, 7-diphenyl-1, 10-phenanthroline) Linne, alq ₃ (tris (8-hydroxyquinoline) aluminum), TSPO1 (diphenyl-4-triphenylsilylphenyl-phosphine oxide), T2T (2, 4, 6-tris (biphenyl-3-yl) -1,3, 5-triazine), T3T (2, 4, 6-tris (terphenyl-3-yl) -1,3, 5-triazine), TST (2, 4, 6-tris (9, 9' -spirobifluorene-2-yl) -1,3, 5-triazine) and/or TCB/TCP (1, 3, 5-tris (N-carbazolyl) benzene/1, 3, 5-tris (carbazol-9-yl) benzene).

Adjacent to the Electron Transport Layer (ETL), a cathode layer C may be positioned. The cathode layer C may, for example, comprise a metal (e.g., al, au, ag, pt, cu, zn, ni, fe, pb, li, ca, ba, mg, in, W or Pd) or a metal alloy, or may consist of a metal (e.g., al, au, ag, pt, cu, zn, ni, fe, pb, li, ca, ba, mg, in, W or Pd) or a metal alloy. For practical reasons the cathode layer may also consist of a (substantially) opaque metal such as Mg, ca or Al. Alternatively or additionally, the cathode layer C may also comprise graphite and/or Carbon Nanotubes (CNTs). Alternatively, the cathode layer C may also be composed of nano-scale silver wires.

The OLED may further optionally include a protective layer (which may be designated as an Electron Injection Layer (EIL)) between the Electron Transport Layer (ETL) and the cathode layer C. The layer may comprise lithium fluoride, cesium fluoride, silver, liq (lithium 8-hydroxyquinoline), li ₂ O、BaF ₂ MgO and/or NaF.

Optionally, the Electron Transport Layer (ETL) and/or the Hole Blocking Layer (HBL) may also comprise one or more host compounds H.

In order to further modify the emission spectrum and/or the absorption spectrum of the luminescent layer EML, the luminescent layer EML may further comprise one or more further emitter molecules F. Such an emitter molecule F may be any emitter molecule known in the art. Preferably, such emitter molecules F are molecules having a structure different from that of the organic molecule E according to the invention. The emitter molecule F may alternatively be a TADF emitter. Alternatively, the emitter molecules F may alternatively be fluorescent and/or phosphorescent emitter molecules capable of shifting the emission spectrum and/or the absorption spectrum of the light emitting layer EML. Illustratively, by emitting light that is typically red shifted compared to light emitted by the organic molecules, triplet and/or singlet excitons may be transferred from the organic molecule E according to the invention to the emitter molecule F before relaxation to the ground state S0. Alternatively, the emitter molecule F may also cause a two-photon effect (i.e., absorption of half the energy of the absorption maximum by two photons).

Alternatively, the optoelectronic device (e.g., OLED) may be, for example, a substantially white optoelectronic device. For example, such a white optoelectronic device may comprise at least one (deep) blue emitter molecule and one or more green and/or red light emitting emitter molecules. Then, energy transfer (energy transmittance) may also optionally be present between two or more molecules as described above.

purple: wavelength range >380nm to 420 nm;

deep blue: wavelength range >420nm to 480 nm;

sky blue: wavelength range >480nm to 500 nm;

green: a wavelength range of >500nm to 560 nm;

yellow: wavelength range of >560nm to 580 nm;

orange: wavelength range of >580nm to 620 nm;

red: wavelength range of >620nm to 800 nm.

For an emitter molecule, this color refers to the emission maximum. Thus, for example, a deep blue emitter has an emission maximum in the range of >420nm to 480nm, a sky blue emitter has an emission maximum in the range of >480nm to 500nm, a green emitter has an emission maximum in the range of >500nm to 560nm, and a red emitter has an emission maximum in the range of >620nm to 800 nm.

The deep blue emitter may preferably have an emission maximum below 480nm, more preferably below 470nm, even more preferably below 465nm or even below 460 nm. It will typically be above 420nm, preferably above 430nm, more preferably above 440nm or even above 450nm.

The green emitter has an emission maximum below 560nm, more preferably below 550nm, even more preferably below 545nm or even below 540 nm. It will typically be above 500nm, more preferably above 510nm, even more preferably above 515nm or even above 520nm.

Thus, a further aspect of the invention relates to an OLED, which is at 1000cd/m ² Exhibits an external quantum efficiency of greater than 8% (more preferably greater than 10%, more preferably greater than 13%, even more preferably greater than 15%, or even greater than 20%) and/or exhibits an emission maximum between 420nm and 500nm (preferably between 430nm and 490nm, more preferably between 440nm and 480nm, even more preferably between 450nm and 470 nm), and/or between 500cd/m ² The following exhibits a LT80 value of greater than 100 hours (preferably greater than 200 hours, more preferably greater than 400 hours, even more preferably greater than 750 hours, or even greater than 1000 hours). Thus, a further aspect of the invention relates to an OLED whose emission exhibits a CIEy color coordinate of less than 0.45 (preferably less than 0.30, more preferably less than 0.20, or even more preferably less than 0.15 or even less than 0.10).

Yet another aspect of the invention relates to an OLED that emits light at different color points. According to the present invention, the OLED emits light having a narrow emission band (small Full Width Half Maximum (FWHM)). In one aspect, an OLED according to the invention emits light having a FWHM of the main emission peak of less than 0.25eV (preferably less than 0.20eV, more preferably less than 0.17eV, even more preferably less than 0.15eV, or even less than 0.13 eV).

Yet another aspect of the invention relates to an OLED emitting light with CIEx (=0.131) and CIEy (=0.046) color coordinates close to CIEx (=0.131) and CIEy (=0.046) color coordinates as primary color blue (ciex=0.131, ciey=0.046) as defined by ITU-R Recommendation bt.2020 (rec.2020), and thus is suitable for application in Ultra High Definition (UHD) displays (e.g., UHD-TV). Thus, a further aspect of the invention relates to an OLED whose emission exhibits CIEx color coordinates between 0.02 and 0.30 (preferably between 0.03 and 0.25, more preferably between 0.05 and 0.20, or even more preferably between 0.08 and 0.18, or even between 0.10 and 0.15) and/or CIEy color coordinates between 0.00 and 0.45 (preferably between 0.01 and 0.30, more preferably between 0.02 and 0.20, or even more preferably between 0.03 and 0.15, or even between 0.04 and 0.10).

In yet another embodiment of the invention, the composition has a photoluminescence quantum yield (PLQY) of greater than 20% (preferably greater than 30%, more preferably greater than 35%, more preferably greater than 40%, more preferably greater than 45%, more preferably greater than 50%, more preferably greater than 55%, even more preferably greater than 60%, or even greater than 70%) at room temperature.

In yet another aspect, the invention relates to a method for fabricating an optoelectronic device. In this case, the organic molecules of the invention are used.

In a further aspect, the invention relates to a method for generating light at a wavelength range of 440nm to 560nm (in particular 440nm to 470 nm), the method comprising the steps of:

(i) Providing an optoelectronic device comprising an inventive organic molecule; and

(ii) A current is applied to the optoelectronic device.

The optoelectronic device (in particular, OLED) according to the invention can be manufactured by any means of vapor deposition and/or liquid treatment. Thus, at least one layer:

-by means of a sublimation process;

-by means of an organic vapour deposition process;

-by means of a carrier gas sublimation process;

-solution treatment or printing.

Methods for fabricating optoelectronic devices (in particular, OLEDs) according to the present invention are known in the art. The different layers are deposited individually and consecutively on a suitable substrate by means of a subsequent deposition process. The layers may be deposited using the same or different deposition methods.

Vapor deposition processes include, for example, thermal (co) evaporation, chemical vapor deposition, and physical vapor deposition. For active matrix OLED displays, the AMOLED backplane serves as a substrate. The individual layers may be treated from solution or dispersion with a suitable solvent. Solution deposition processes include, for example, spin coating, dip coating, and jet printing. The liquid treatment may optionally be carried out in an inert atmosphere (e.g., in a nitrogen atmosphere), and the solvent may be removed completely or partially by means known in the art.

In another aspect, the invention also relates to a luminescent molecule comprising or consisting of the structure of formula 100:

wherein,

n=0 or 1;

x is independently selected at each occurrence from the group consisting of direct bond, CR ³ R ⁴ 、C＝CR ³ R ⁴ 、C＝O、C＝NR ³ 、NR ³ 、O、SiR ³ R ⁴ S, S (O) and S (O) ₂ A group of;

R ¹ 、R ² 、R ³ 、R ⁴ 、R ^I 、R ^II 、R ^III 、R ^IV and R is ^V Selected from the group consisting of: hydrogen; deuterium; n (R) ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；B(R ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ An alkoxy group, an amino group,optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ ；

R ^d And R is ^e Independently selected from the group consisting of: hydrogen; deuterium; CF (compact flash) ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ^a And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ^a The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ^a ；

R ^a Independently at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；B(R ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thio-Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ ；

R ⁵ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁶ ) ₂ ；OR ⁶ ；Si(R ⁶ ) ₃ ；B(OR ⁶ ) ₂ ；B(R ⁶ ) ₂ ；OSO ₂ R ⁶ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals may beOptionally by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁶ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁶ ；

R ⁶ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; OPh; CF (compact flash) ₃ ；CN；F；C ₁ -C ₅ Alkyl, wherein one or more hydrogen atoms are optionally replaced by deuterium, CN, CF independently of one another ₃ Or F substitution; c (C) ₁ -C ₅ Alkoxy, wherein one or more hydrogen atoms are optionally replaced by deuterium, CN, CF independently of one another ₃ Or F substitution; c (C) ₁ -C ₅ Thioalkoxy groups in which one or more hydrogen atoms are optionally replaced by deuterium, CN, CF independently of one another ₃ Or F substitution; c (C) ₂ -C ₅ Alkenyl in which one or more hydrogen atoms are optionally replaced independently of one another by deuterium, CN, CF ₃ Or F substitution; c (C) ₂ -C ₅ Alkynyl, wherein one or more hydrogen atoms are optionally replaced independently of each other by deuterium, CN, CF ₃ Or F substitution; c (C) ₆ -C ₁₈ Aryl optionally substituted with one or more C ₁ -C ₅ An alkyl substituent; c (C) ₂ -C ₁₇ Heteroaryl, optionally substituted with one or more C ₁ -C ₅ An alkyl substituent; n (C) ₆ -C ₁₈ Aryl group ₂ ；N(C ₂ -C ₁₇ Heteroaryl group ₂ The method comprises the steps of carrying out a first treatment on the surface of the N (C) ₂ -C ₁₇ Heteroaryl) (C) ₆ -C ₁₈ An aryl group);

wherein the substituents R ^a 、R ^d 、R ^e And R is ⁵ Independently of one another optionally together with one or more substituents R ^a 、R ^d 、R ^e And R is ⁵ Forming a mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system; and is also provided with

Wherein the substituents R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ 、R ^I 、R ^II 、R ^III 、R ^IV And R is ^V Independently of one another optionally together with one or more substituents R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ 、R ^I 、R ^II 、R ^III 、R ^IV And R is ^V Forming a mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system.

Example

General Synthesis scheme I

/>

General procedure for synthesis:

AAV5: e1 (1.00 eq.) was dissolved in anhydrous chloroform or dichloromethane or DMF. N-bromosuccinimide (CAS: 128-08-5,1.05 eq.) was added in portions at 0deg.C under nitrogen. The mixture was stirred at room temperature for 2 hours, then extracted between chloroform and water, and the combined organic layers were concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E2 as a solid.

AAV6: e2 (1.00 eq.), bis (pinacolato) diboron (CAS: 73183-34-3,1.5 eq.), [1,1' -bis (diphenylphosphino) ferrocene ] palladium (II) dichloride (CAS: 72287-26-4,0.02 eq.) and potassium acetate (KOAc; CAS:127-08-2,3.00 eq.) were stirred under reflux in anhydrous dioxane under nitrogen for 24 hours. After cooling to room temperature (rt), the reaction mixture was extracted between dichloromethane and water, and the combined organic layers were concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E3 as a solid.

AAV5a: e1a (1.00 eq.) was dissolved in anhydrous chloroform or dichloromethane or DMF. N-bromosuccinimide (CAS: 128-08-5,2.70 eq.) was added in portions at 0deg.C under nitrogen. After warming to rt, stirring was continued at room temperature for 24 hours. Subsequently, the mixture was extracted between chloroform and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E2a as a solid.

AAV6a: e2a (1.0 eq.), E5 (2.50 eq.), tetrakis (triphenylphosphine) palladium (0) (CAS number: 14221-01-3,0.08 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,5.0 eq.) in a mixture of dioxane and water (4:1 by volume) for 1 hour. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, the compound is obtained as a solidObject E2b.

AAV6b: e2b (1.00 eq.), bis (pinacolato) diboron (CAS: 73183-34-3,2.0 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS: 51364-51-3,0.02 eq.), X-Phos (CAS: 564483-18-7,0.08 eq.) and potassium acetate (KOAc; CAS:127-08-2,4.00 eq.) are stirred in anhydrous dioxane at 100℃under nitrogen atmosphere for 1 hour. After cooling to room temperature (rt), the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E3a as a solid.

AAV7: e4 (1.00 eq), E5 (1.50 eq), tris (dibenzylideneacetone) dipalladium (0) (CAS: 51364-51-3,0.01 eq), S-Phos (CAS: 657408-07-6,0.04 eq) and tripotassium phosphate (CAS: 7778-53-2, 30 eq) were stirred under reflux in dioxane/water (4:1 by volume) under a nitrogen atmosphere. After cooling to room temperature (rt), the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried and concentrated under reduced pressure. The crude product is purified by column chromatography or recrystallization. E6 was obtained as a solid.

AAV7b: e4b (1.00 eq) was dissolved in anhydrous DMF. N-chlorosuccinimide (CAS: 128-09-6,1.00 equivalents) was added in portions at 75℃under a nitrogen atmosphere. The temperature was maintained at 75℃for 2 hours. The reaction was then quenched by the addition of water and ethyl acetate. The phases were separated and the organic layer was washed with water. With anhydrous MgSO ₄ The organic layer was dried, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E4c as a solid.

AAV8: e6 (1.00 eq.) was dissolved in anhydrous DMF. N-bromosuccinimide (CAS: 128-08-5,1.00 eq.) was added in portions at 0deg.C under nitrogen. The temperature was maintained at 0℃for 5 hours. The reaction was then quenched by the addition of water and ethyl acetate. The phases were separated and the organic layer was washed with water. With anhydrous MgSO ₄ The organic layer was dried, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography or recrystallization to obtain E7 as a solid.

AAV9: e7 (1.0 equivalent), E5 (2.5 equivalentAmount), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 equivalent), X-Phos (CAS No.: 564483-18-7,0.04 eq) and K ₃ PO ₄ (CAS number 7778-53-2,5.0 eq.) in a mixture of dioxane and water (4:1 by volume) for 24 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound E8 was obtained as a solid.

AAV9b: e4c (1.0 eq.), E5b (3.0 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq.), X-Phos (CAS number: 564483-18-7,0.04 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,5.0 eq.) in a mixture of dioxane and water (4:1 by volume) for 24 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound E9b was obtained as a solid.

AAV10: e8 (1.0 eq), I-4 (1.05 eq) and Cs ₂ CO ₃ The suspension (CAS number 534-17-8,3.0 eq.) was stirred in anhydrous DMF at 130℃for 12 hours. After cooling to rt, water and ethyl acetate were added and the phases separated. The combined organic layers were washed with water, dried over anhydrous MgSO ₄ Dried, filtered and concentrated. Purification of the crude product by recrystallization or column chromatography gives compound I-5 as a solid.

AAV10a: a suspension of E9 (1.05 eq.), I-4a (1.0 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.02 eq.), tri-tert-butylphosphine (CAS number: 13716-12-6,0.08 eq.) and sodium tert-butoxide (CAS number: 865-48-5,2.5 eq.) in degassed toluene was stirred at 80℃for 18 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-5a was obtained as a solid.

AAV10b: a suspension of E9b (1.05 eq.), I-4a (1.6 eq.), cuprous iodide (I) (CAS number 7681-65-4,0.15 eq.), 1, 10-phenanthroline (CAS number 66-71-7,0.3 eq.) and cesium carbonate (CAS number 534-17-8,1.5 eq.) in degassed DMF was stirred at 115℃for 24 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-5b was obtained as a solid.

AAV10c: a suspension of E12 (1.0 eq), I-12 (1.1 eq), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.06 eq.), tri-tert-butylphosphine (CAS number: 13716-12-6,0.12 eq.) and sodium tert-butoxide (CAS number: 865-48-5,5.0 eq.) in degassed toluene was stirred at 100℃for 24 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-13 was obtained as a solid.

AAV10d: a suspension of E13 (1.0 eq), I-14 (1.0 eq), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq), tri-tert-butylphosphine (CAS number: 13716-12-6,0.04 eq) and sodium tert-butoxide (CAS number: 865-48-5,3.0 eq) in degassed toluene was stirred at 80℃for 18 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-15 was obtained as a solid.

AAV10e: e9b (1.0 eq), I-14b (1.0 eq) and K ₃ PO ₄ The suspension (CAS number 7778-53-2,2.0 eq.) was stirred in anhydrous DMSO at 110℃for 18 hours. After cooling to rt, water and ethyl acetate were added and the phases separated. The combined organic layers were washed with water, dried over anhydrous MgSO ₄ Dried, filtered and concentrated. Purification of the crude product by recrystallization or column chromatography gives compound I-15b as a solid.

AAV11: i-5 (1.0 equivalent), I-6 (1.10 equivalent), tetrakis (triphenylphosphine) palladium (0) (CAS number: 14221-01-3,0.05 equivalent) and K ₃ PO ₄ (CAS number 7778-53-2,2.0 eq.) in a mixture of dioxane and water (4:1 by volume) for 24 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ DryingThe combined organic layers were filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-7 was obtained as a solid.

AAV12: i-7 (1.0 equivalent), E3 (1.3 equivalent), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.015 equivalent), X-Phos (CAS number: 564483-18-7,0.06 equivalent) and K ₃ PO ₄ (CAS number 7778-53-2,3.6 eq) in a mixture of dioxane and water (4:1 by volume) for 4 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-8 was obtained as a solid.

AAV12a: i-5a (1.0 eq.), E3 (1.3 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.015 eq.), S-Phos (CAS number: 657408-07-6,0.06 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,3.6 eq.) in a mixture of THF and water (5:1 by volume) for 4 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-8a was obtained as a solid.

AAV12b: i-5b (1.0 eq.), E3 (1.1 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.015 eq.), S-Phos (CAS number: 657408-07-6,0.06 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,3.6 eq) in a mixture of dioxane and water (4:1 by volume) for 4 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-8b was obtained as a solid.

AAV12c: i-15 (1.2 eq.), E3 (1.0 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq.), S-Phos (CAS number: 657408-07-6,0.04 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,2.0 equivalents) in a mixture of dioxane and water (4:1 by volume). After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-16 was obtained as a solid.

AAV12d: i-15b (1.0 eq.), E3 (1.10 eq.), tetrakis (triphenylphosphine) palladium (0) (CAS number: 14221-01-3,0.05 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,2.0 eq.) in a mixture of dioxane and water (4:1 by volume) for 24 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-16b was obtained as a solid.

AAV13: to a solution of I-8 (1.0 eq.) in anhydrous chlorobenzene (20 mL per 1mmol I-8) was added boron tribromide (99%, CAS number 10294-33-4,4.0 eq.) at 0deg.C. The mixture was warmed to rt and then heated at 50 ℃ for 24 hours. The mixture was cooled to rt. Subsequently, the mixture was extracted between water and ethyl acetate, and dried over anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated. After purification by recrystallization or column chromatography, the target compound P-2 was obtained as a solid.

AAV13a: to a solution of I-8a (1.0 eq.) in anhydrous chlorobenzene (20 mL per 1mmol of I-8 a) was added boron tribromide (99%, CAS number 10294-33-4,4.0 eq.) at 0deg.C. The mixture was warmed to rt and then heated at 50 ℃ for 24 hours. The mixture was cooled to rt. Subsequently, the mixture was extracted between water and ethyl acetate, and dried over anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated. After purification by recrystallization or column chromatography, the target compound P-2 was obtained as a solid.

AAV13b: to a solution of I-8b (1.0 eq.) in anhydrous chlorobenzene (20 mL per 1mmol I-8 b) was added boron tribromide (99%, CAS number 10294-33-4,4.0 eq.) at 0deg.C. The mixture was warmed to rt and then heated at 50 ℃ for 24 hours. The mixture is mixedCooled to rt. Subsequently, the mixture was extracted between water and ethyl acetate, and dried over anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated. After purification by recrystallization or column chromatography, the target compound P-2 was obtained as a solid.

AAV14: i-9 (1.0 eq.), E3 (1.0 eq.), tetrakis (triphenylphosphine) palladium (0) (CAS number: 14221-01-3,0.04 eq.) and K ₃ PO ₄ (CAS number 7778-53-2,2.5 eq.) in a degassed mixture of dioxane and water (4:1 by volume) for 2 hours. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-10 was obtained as a solid.

AAV15: a suspension of E10 (1.05 eq), I-10 (1.0 eq), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.02 eq), tri-tert-butylphosphonium tetrafluoroborate (CAS number: 131274-22-1,0.08 eq) and sodium tert-butoxide (CAS number: 865-48-5,2.5 eq) in degassed ortho-xylene was stirred under reflux for 24 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-11 was obtained as a solid.

AAV16: a suspension of I-11 (1.05 eq.), E11 (1.0 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.02 eq.), tri-tert-butylphosphine (CAS number: 13716-12-6,0.08 eq.) and sodium tert-butoxide (CAS number: 865-48-5,2.5 eq.) in degassed toluene or toluene was stirred at 80℃for 18 hours. After cooling to room temperature (rt), aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-12 was obtained as a solid.

AAV17: i-17 (1.0 equivalent), E13 (1.5 equivalent), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.02 equivalent), X-Phos (CAS number: 564483-18-7,0.08 equivalent) and K ₃ PO ₄ (CAS number 7778-53-2,1.5 eq) in a mixture of dioxane and water (4:1 by volume) for 4 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ Drying boxAnd the organic layer was filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound P-2 was obtained as a solid.

AAV18: i-18 (1.00 eq.) was dissolved in anhydrous DMF. Sodium hydride (CAS: 7646-69-7,1.5 eq.) was added in portions at room temperature (rt) under nitrogen. The mixture was stirred at room temperature for 15 minutes, followed by dropwise addition of methyl iodide (CAS: 74-88-4,1.25 equivalents). After stirring for 4 hours, an aqueous work-up is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-19 was obtained as a solid.

AAV19: i-19 (1.0 equivalent), E5b (1.3 equivalent), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 equivalent), X-Phos (CAS number: 564483-18-7,0.04 equivalent), and K ₃ PO ₄ (CAS number 7778-53-2,3.0 eq.) in a mixture of toluene and water (4:1 by volume) at 80℃for 8 hours. After cooling to rt, the reaction mixture was extracted between ethyl acetate and water. With anhydrous MgSO ₄ The combined organic layers were dried, filtered and concentrated under reduced pressure. After purification by recrystallization or column chromatography, compound I-20 was obtained as a solid.

AAV20: to a solution of I-20 (1.0 eq.) in anhydrous TBB (20 mL per 1mmol I-8 b) was added tert-butyllithium (CAS number: 594-19-4,3.0 eq.). The mixture was warmed to rt and then heated at 50 ℃ for 4 hours. The mixture was cooled to rt. Subsequently, boron trichloride (CAS number 10294-34-5,4.5 eq.) was added at-78℃and the reaction mixture was stirred at 50℃for 24 hours. After stirring for 24 hours, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound P2 was obtained as a solid.

Example 19 was synthesized using step 1:

a suspension of I-21 (1.00 eq.) in degassed dioxane/water (CAS number 202865-57-4), tetrakis (triphenylphosphine) palladium (0) (CAS number 14221-01-3,0.05 eq.) and potassium carbonate (CAS number 584-08-7,3.0 eq.) was stirred and I-22 (1.1 eq.) was added in portions (CAS number 1510810-80-6). After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography.

The desired compound I-23 was obtained as a solid.

Sodium hydride (1.5 eq) (CAS number 7646-69-7) was added in portions to a suspension of I-23 (1.00 eq) (CAS number 202865-57-4) at rt under stirring, followed by methyl iodide (1.25 eq) (CAS number 74-88-4) for 1 hour. In the presence of 10% NH ₃ After precipitation, the desired compound I-24 was obtained as a solid.

I-24 (1.00 eq.), I-25 (CAS number: 6825-20-3,1.2 eq.) and potassium phosphate (CAS number: 7778-53-2,2.4 eq.) were stirred in anhydrous DMSO at 130℃until complete. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-26 was obtained as a solid.

A suspension of I-26 (1.00 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.02 eq.), X-Phos (CAS number: 564483-18-7,0.08 eq.), potassium phosphate (CAS number: 7778-53-2,6 eq.) in degassed dioxane/water was stirred and I-27 (4 eq.) (CAS number: 123324-71-0) was added dropwise. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-28 was obtained as a solid.

A suspension of I-28 (1.00 eq.) boron tribromide (CAS number 10294-33-4,2.00 eq.) and boron trichloride (CAS number 10294-34-5,2.00 eq.) in degassed meta-xylene was stirred, tert-butyllithium (CAS number 594-19-4,3.00 eq.) was added and the reaction mixture stirred at 70℃for 4 hours 30 minutes. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. Example 19 of the desired compound was obtained as a solid.

Example 20 was synthesized using step 2:

a suspension of I-21 (1.00 eq.) and potassium phosphate (CAS number: 202865-57-4) (CAS number: 7778-53-2,2.0 eq.) in anhydrous DMSO was stirred and the temperature was raised to 110 ℃. I-30 (CAS number 56525-79-2,1.15 eq.) was added in portions during stirring. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-31 was obtained as a solid.

Stirring I-31 (1.00 eq.) PdCl ₂ (dppf) (CAS number: 72287-26-4,0.04 eq.) and potassium phosphate (CAS number: 7778-53-2,3.0 eq.) in degassed dioxane/water. A solution of I-32 (1.00 eq) (CAS number 1510810-80-6) in degassed dioxane was added to the reaction mixture at 80 ℃. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-33 was obtained as a solid.

A suspension of I-33 (0.63 eq.), I-34 (3, 5-di-tert-butylphenylboronic acid) (CAS number: 197223-39-5,1.2 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq.), X-Phos (CAS number: 564483-18-7,0.04 eq.) and potassium phosphate (CAS number: 7778-53-2,3.5 eq.) in degassed toluene/water was stirred at 100℃for 13h. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-35 was obtained as a solid.

Sodium hydride (1.5 eq) (CAS number 7646-69-7) was added in portions to a stirred suspension of I-35 (1.00 eq) (CAS number 202865-57-4) at room temperature, followed by methyl iodide (1.25 eq) (CAS number 74-88-4) for 1 hour. In the presence of 10% NH ₃ After precipitation, the desired compound I-36 was obtained as a solid.

A suspension of I-36 (1.00 eq.) boron tribromide (CAS number 10294-33-4,2.00 eq.) and boron trichloride (CAS number 10294-34-5,2.00 eq.) in anhydrous TBB was stirred, tert-butyllithium (CAS number 594-19-4,3.00 eq.) was added and the reaction mixture stirred at 70℃for 4 hours 30 minutes. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. Example 20 of the desired compound was obtained as a solid.

Example 21 was synthesized using step 3:

a suspension of I-37 (1.00 eq.), I-38 (2, 6-dimethylphenylboronic acid) (CAS number: 100379-00-8,2.5 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq.), S-Phos (CAS number: 564483-18-7,0.04 eq.) and potassium phosphate (CAS number: 7778-53-2,3.00 eq.) in degassed toluene/water was stirred overnight at 100 ℃. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-39 was obtained as a solid.

A suspension of I-39 (1.00 eq.) in anhydrous DMF was heated to 140℃and I-21 (2.00 eq.) (CAS number: 202865-57-4) and cesium carbonate (CAS number: 534-17-8,3.0 eq.) were added. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography.

The desired compound I-40 was obtained as a solid.

A suspension of I-41 (1.00 eq), I-40 (1.00 eq), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.04 eq), potassium phosphate (CAS number: 7778-53-2,3.00 eq) in degassed dioxane/water was stirred overnight at 100℃until complete. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-42 was obtained as a solid.

Sodium hydride (1.5 eq) (CAS number 7646-69-7) was added in portions to a stirred suspension of I-42 (1.00 eq) (CAS number 202865-57-4) at rt, followed by methyl iodide (1.25 eq) (CAS number 74-88-4) for 1 hour. In the presence of 10% NH ₃ After precipitation, the desired compound I-43 was obtained as a solid.

A suspension of I-43 (1.00 eq.), I-44 (phenylboronic acid) (CAS number: 98-80-6,1.3 eq.), tris (dibenzylideneacetone) dipalladium (0) (CAS number: 51364-51-3,0.01 eq.), X-Phos (CAS number: 564483-18-7,0.04 eq.) and potassium phosphate (CAS number: 7778-53-2,3.00 eq.) in degassed toluene/water was stirred overnight at 100 ℃. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. The desired compound I-45 was obtained as a solid.

A suspension of I-45 (1.00 eq.) boron tribromide (CAS number 10294-33-4,2.00 eq.) and boron trichloride (CAS number 10294-34-5,2.00 eq.) in anhydrous TBB was stirred, tert-butyllithium (CAS number 594-19-4,3.00 eq.) was added and the reaction mixture stirred at 70℃for 4 hours 30 minutes. After cooling to rt, aqueous workup is carried out, and the crude product is then purified by recrystallisation or column chromatography. Example 21 of the desired compound was obtained as a solid.

Cyclic voltammetry

Cyclic voltammograms are obtained by having a concentration of 10 in methylene chloride or a suitable solvent and a suitable supporting electrolyte (e.g., 0.1mol/L tetrabutylammonium hexafluorophosphate) ^-3 measured in a solution of organic molecules in mol/L. Measurements were performed at room temperature under nitrogen atmosphere using a three-electrode assembly (working and counter electrodes: pt line, reference electrode: pt line), and FeCp was used ₂ /FeCp ₂ ⁺ Calibration was performed as an internal standard. HOMO data were corrected for Saturated Calomel Electrodes (SCEs) using ferrocene as an internal standard.

Theoretical calculation of Density functional

The molecular structure was optimized using BP86 functional and consistency check method (RI, resolution of identity approach). The excitation energy is calculated using (BP 86) optimized structure using a time dependent DFT (TD-DFT) method. The orbital and excited state energies were calculated using the B3LYP functional. The Def2-SVP basis set and an m4 grid for numerical integration are used. The turbo program package is used for all calculations.

Absorption measurement

Thermo Scientific Evolution 201 UV-visible spectrophotometers are used to determine the wavelength of the absorption maximum of a sample in the wavelength region greater than 270 nm. This wavelength is used as excitation wavelength for photoluminescence spectra and photoluminescence quantum yield measurements.

Photophysical measurement

Sample pretreatment: and (5) spin coating.

Instrument: spin150, SPS euro.

The sample concentration was 10mg/mL, dissolved in a suitable solvent.

The procedure is as follows: 1) At 400U/min for 3 seconds. 2) At 1000U/min, at 1000Upm/s for 20 seconds. 3) At 4000U/min at 1000Upm/s for 10 seconds. After coating, the film was dried at 70 ℃ for 1min.

Photoluminescence spectra and time dependent single photon counting (TCSPC)

Steady state emission spectra were measured by Horiba Scientific, modell FluoMax-4 equipped with a 150W xenon arc lamp, excitation and emission monochromator, and a Hamamatsu R928 photomultiplier and time-dependent single photon counting option. The emission and excitation spectra were corrected using a standard correction fit.

The excited state lifetime was determined using the TCSPC method with the same architecture as the FM-2013 device and Horiba Yvon TCSPC hub.

Excitation source:

nanometer LED 370 (wavelength 371nm, pulse duration 1.1 ns)

Nanometer LED 290 (wavelength 294nm, pulse duration: <1 ns)

Spectral LED 310 (wavelength 314 nm)

Spectral LED 355 (wavelength: 355 nm).

Data analysis (exponential fit) was done using software suite DataStation and DAS6 analysis software. The fit was specified using chi-square test.

Photoluminescence quantum yield measurement

For photoluminescence quantum yield (PLQY) measurements, the C9920-03G system was measured using absolute PL quantum yield (Hamamatsu Photonics). Quantum yields and CIE coordinates were determined using software U6039-05 version 3.6.0.

Emission maxima are given in nm, quantum yield Φ _PL The CIE coordinates are given as x-values, y-values in%.

PLQY is determined using the following protocol:

1) And (3) quality assurance: using anthracene (known concentration) in ethanol as a reference

2) Excitation wavelength: determining the absorption maximum of an organic molecule, exciting the organic molecule using the wavelength

3) Measurement of

For samples of the solution or film, the quantum yield was measured under nitrogen atmosphere. Yield was calculated using the equation:

wherein n is _{Photons (photon)} Representing photon count, int.

Fabrication and characterization of optoelectronic devices

Optoelectronic devices (such as OLED devices) comprising organic molecules according to the invention can be manufactured via vacuum deposition methods. If the layer contains more than one compound, the weight percentage of one or more compounds is given in%. The total weight percentage value is 100% and therefore if no value is given, the fraction of this compound is equal to the difference between the given value and 100%.

The fully optimized OLED was characterized using standard methods and measuring the electroluminescence spectrum, the external quantum efficiency (in%) dependent on intensity calculated using light and current detected by the photodiode. OLED device lifetime is extracted from the change in brightness during operation at constant current density. The LT50 value corresponds to a point in time when the measured luminance decreases to 50% of the initial luminance, similarly, the LT80 value corresponds to a point in time when the measured luminance decreases to 80% of the initial luminance, the LT95 value corresponds to a point in time when the measured luminance decreases to 95% of the initial luminance, and so on.

Accelerated life measurements are made (e.g., using increased current density). For example, the following equation is used to determine the value at 500cd/m ² The following LT80 values:

wherein L is ₀ Representing the initial brightness at the applied current density.

This value corresponds to the average of several (typically two to eight) pixels, giving the standard deviation between these pixels.

HPLC-MS

HPLC-MS analysis was performed on HPLC with Agilent (1100 series) having MS detector (Thermo LTQ XL).

Exemplary, typical HPLC methods are as follows: reversed-phase chromatography column 4.6 mm. Times.150 mm from Agilent was used in HPLC, particle size 3.5 μm (ZORBAX Eclipse Plus) C18, 4.6 mm. Times.150 mm, 3.5 μm HPLC column). HPLC-MS measurements were performed at room temperature (rt) with the following gradient:

flow rate

The following solvent mixtures were used:

solvent a:	H ₂ O(90％)	MeCN(10％)
			solvent B:	H ₂ O(10％)	MeCN(90％)
solvent C:	THF(50％)	MeCN(50％)

the measurement was performed with an amount of 5. Mu.L of sample from a solution of the analyte having a concentration of 0.5 mg/mL.

Ionization of the probe was performed in either positive (apci+) or negative (APCI-) ionization modes using an APCI (atmospheric pressure chemical ionization) source.

Example 1

Example 1 was synthesized according to the following procedure:

AAV5a (49% yield), wherein E1a is represented by 1-chloro-9H-carbazole (CAS: 5599-70-2);

AAV6a (53% yield), wherein E2a and E5 are represented by 3, 6-dibromo-1-chloro-9H-carbazole (CAS: 2619632-07-2) and o-tolylboronic acid (CAS: 16419-60-6), respectively;

AAV6b (49% yield);

AAV7 (quantitative yield), wherein compound E4 and compound E5 are represented by 5-bromo-7H-benzo [ c ] carbazole (CAS: 131409-18-2) and 2, 6-dimethylphenylboronic acid (CAS: 100379-00-8), respectively;

AAV8 (63% yield);

AAV9 (17% yield), wherein compound E5 is represented by metaboric acid (CAS: 13061-96-6);

AAV10 (77% yield), wherein compound I-4 is represented by 1-bromo-3-chloro-5-fluoro-2-methylbenzene (CAS: 1780876-62-1);

AAV11 (65% yield), wherein Compound I-6 consists of 2, 6-dimethylphenylboronic acid (CAS: 100379-00-8);

AAV12 (52% yield);

and AAV13 (17% yield).

MS (LC-MS, APPI ion source): 884m/z, rt is at: 8.66min.

The emission maximum of example 1 (0.001 mg/mL in toluene) was at 454nm, CIEx coordinates were 0.14, CIEy coordinates were 0.08, PLQY was 87%.

The absorption maximum of example 1 (0.01 mg/mL in toluene) was at 445nm and the molar extinction coefficient at the absorption maximum was 49000M ^-1 cm ^-1 。

The emission maximum in example 1 (1 wt% in mCBP) in the doped film was 458nm, ciex coordinates were 0.14, ciey coordinates were 0.10.

Example 2

Example 2 was synthesized according to the following steps:

AAV10a (86% yield), wherein E9 is represented by phenoxazine (CAS: 135-67-1);

AAV12a (71% yield), wherein I-5a and E3 are represented by 10- (3-chlorophenyl) -10H-phenoxazine and 1- (tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole (CAS: 1219637-88-3), respectively;

AAV13a (8% yield), wherein compound I-8a is represented by 10- (3- (9H-carbazol-1-yl) phenyl) -10H-phenoxazine;

example 3

Example 3 was synthesized according to the following procedure:

AAV14 (70% yield), wherein I-9 and E3 are represented by 4-bromonaphthalen-2-amine (CAS: 74924-94-0) and 3, 6-bis (1, 1-dimethylethyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole (CAS: 1510810-80-6), respectively;

AAV15 (65% yield), wherein I-10 and E10 are represented by 4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-amine and 1-bromo-3, 5-di-tert-butylbenzene (CAS: 22385-77-9), respectively;

AAV16 (75% yield), wherein I-11 and E11 are represented by 4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) -N- (3, 5-di-tert-butylphenyl) naphthalen-2-amine and 3-bromo-9-phenyl-9H-carbazole (CAS: 1153-85-1), respectively;

AAV13 (16% yield), wherein compound I-8 is represented by N- (4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-yl) -N- (3, 5-di-tert-butylphenyl) -9-phenyl-9H-carbazol-3-amine;

MS (LC-MS, APPI ion source): 859m/z, rt is at: 8.85min.

The emission maximum of example 3 (0.001 mg/mL in toluene) was 544nm and the full width at half maximum (FWHM) was 32nm, CIEx coordinates were 0.39, CIEy coordinates were 0.59, PLQY was 77%.

Example 4

Example 4 was synthesized according to the following procedure:

AAV5 (25% yield), wherein E1 is represented by 3, 6-diphenylcarbazole (CAS: 56525-79-2);

AAV6 (49% yield), wherein E2 is represented by 1-bromo-3, 6-diphenyl-9H-carbazole;

AAV14 (quantitative yield), wherein compound I-9 and compound E3 are represented by 4-bromonaphthalen-2-amine (CAS: 74924-94-0) and 3, 6-bis (phenyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole, respectively;

AAV15 (62% yield), wherein compound I-10 and compound E10 (2.2 equivalents instead of 1.05 equivalents) are represented by 4- (3, 6-diphenyl-9H-carbazol-1-yl) naphthalen-2-amine and 5-bromoindolo [3,2,1-jk ] carbazole (CAS: 109589-98-2), respectively;

AAV13b (4% yield), wherein compound I-8b is represented by N- (4- (3, 6-diphenyl-9H-carbazol-1-yl) naphthalen-2-yl) -N- (indolo [3,2,1-jk ] carbazol-5-yl) indol [3,2,1-jk ] carbazol-5-amine.

MS (LC-MS, APPI ion source): 433m/z, rt is at: 8.59min.

The emission maximum of example 4 (0.001 mg/mL in toluene) was 541nm and the full width at half maximum (FWHM) was 33nm, the CIEx coordinate was 0.33, and the CIEy coordinate was 0.51.

Example 5

Example 5 was synthesized according to the following procedure:

AAV12b (48% yield), wherein compound I-5b and compound E3 are represented by 7- (3-chloro-4-methylbenzene) -7H-dibenzo [ c, g ] carbazole and 3, 6-bis (1, 1-dimethylethyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole (CAS: 1510810-80-6), respectively;

AAV13b (2% yield), wherein I-8b is represented by 7- (3, 6-di-tert-butyl-9H-carbazol-1-yl) -4-methylphenyl) -7H-dibenzo [ c, g ] carbazole.

MS (LC-MS, APPI ion source): 643m/z, rt is at: 8.25min.

Example 5 (0.001 mg/mL in toluene) has an emission maximum at 472nm and a full width at half maximum (FWHM) of 28nm, CIEx coordinates of 0.13, CIEy coordinates of 0.22, PLQY of 82%.

Example 6

Example 6 was synthesized according to the following procedure:

AAV10b (85% yield), wherein compound E9b and compound I-4a are represented by 3,4:5, 6-dibenzocarbazole (CAS: 194-59-2) and 2-chloro-4-iodotoluene (CAS: 83846-48-4), respectively;

AAV15 (46% yield), wherein compound I-10 and compound E10 are represented by 4- (3, 6-diphenyl-9H-carbazol-1-yl) naphthalen-2-amine and 2-bromobenzophenanthrene (CAS: 19111-87-6), respectively;

AAV13b (2% yield), wherein I-8b is represented by N- (4- (3, 6-diphenyl-9H-carbazol-1-yl) naphthalen-2-yl) -N- (triphenyl2-yl) triphenyl2-amine.

MS (LC-MS, APPI ion source): 923m/z, rt is at: 8.31min.

The emission maximum of example 6 (0.001 mg/mL in toluene) was 529nm and the full width at half maximum (FWHM) was 31nm, CIEx coordinates were 0.32, CIEy coordinates were 0.65, PLQY was 96%.

Example 7

Example 7 was synthesized according to the following procedure:

AAV15 (70% yield), wherein I-10 and E10 (2.05 equivalents instead of 1.05 equivalents) are represented by 4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-amine and 3-bromo-9-phenyl-9H-carbazole (CAS: 1153-85-1), respectively;

AAV13b (14% yield), wherein I-8b is represented by N- (4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-yl) -9-phenyl-N- (9-phenyl-9H-carbazol-3-yl) -9H-carbazol-3-amine.

MS (LC-MS, APPI ion source): 912m/z, rt is at: 8.24min.

The emission maximum of example 7 (0.001 mg/mL in toluene) was 541nm and the full width at half maximum (FWHM) was 36nm, CIEx coordinates were 0.38, CIEy coordinates were 0.61, PLQY was 74%.

Example 8

Example 8 was synthesized according to the following procedure:

AAV16 (77% yield), wherein I-11 and E11 are represented by 4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) -N- (3, 5-di-tert-butylphenyl) naphthalen-2-amine and 2-bromobenzophenanthrene (CAS: 19111-87-6), respectively;

AAV13b (24% yield), wherein I-8b is represented by N- (4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-yl) -N- (3, 5-di-tert-butylphenyl) triphenyl2-amine.

MS (LC-MS, APPI ion source): 844m/z, rt is at: 9.29min.

The emission maximum of example 8 (0.001 mg/mL in toluene) was 525nm and the full width at half maximum (FWHM) was 30nm, the CIEx coordinate was 0.30, and the CIEy coordinate was 0.66.

Example 9

Example 9 was synthesized according to the following steps:

AAV10c (47% yield), wherein I-12 and E12 are represented by 1-bromo-3, 5-diphenylbenzene (CAS: 103068-20-8) and 2',4',6 '-trimethyl- [1,1' -biphenyl ] -4-amine, respectively;

AAV10d (48% yield), wherein I-14 and E13 are represented by 5-bromo-1, 3-dichloro-2-methylbenzene (CAS: 204930-37-0) and N- (2 ',4',6' -trimethyl- [1,1' -biphenyl ] -4-yl) - [1,1':3',1 "-terphenyl ] -5' -amine, respectively;

AAV12c (32% yield), wherein I-15 and E3 are represented by N- (3, 5-dichloro-4-methylphenyl) -N- (2 ',4',6' -trimethyl- [1,1' -biphenyl ] -4-yl) - [1,1':3',1 "-terphenyl ] -5' -amine and 8- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -7H-benzo [ c ] carbazole, respectively;

AAV13b (65% yield), wherein I-8b is represented by N- (3- (7H-benzo [ c ] carbazol-8-yl) -5-chloro-4-methylphenyl) -N- (2 ',4',6' -trimethyl- [1,1' -biphenyl ] -4-yl) - [1,1':3',1 "-terphenyl ] -5' -amine;

AAV17 (52% yield), wherein I-17 and E13 are represented by 5- ([ 1,1':3',1 '-terphenyl ] -5' -yl) -7-chloro-2-mesityl-8-methyl-5H-5, 17 b-diaza-17 c-borabenzo [ gh ] benzo [6,7] indeno [1,2,3-no ] tetraphenyl and 3-cyanophenylboronic acid (CAS: 150255-96-2), respectively.

MS (LC-MS, APPI ion source): 855m/z, rt is at: 7.41min.

The emission maximum of example 9 (0.001 mg/mL in toluene) was 452nm and the full width at half maximum (FWHM) was 32nm, CIEx coordinates were 0.14, CIEy coordinates were 0.08, PLQY was 82%.

Example 10

Example 10 was synthesized according to the following steps:

AAV12c (20% yield), wherein I-15 and E3 are represented by N- (3, 5-dichloro-4-methylphenyl) -N- (2 ',4',6' -trimethyl- [1,1' -biphenyl ] -4-yl) - [1,1':3',1 "-terphenyl ] -5' -amine and 3, 6-bis-trimethylphenyl-1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole, respectively;

AAV13b (65% yield), wherein I-8b is represented by N- (3-chloro-5- (3, 6-dimethylisophenyl-9H-carbazol-1-yl) -4-methylphenyl) -N- (2 ',4',6' -trimethyl- [1,1' -biphenyl ] -4-yl) - [1,1':3',1 "-terphenyl ] -5' -amine;

AAV17 (15% yield), wherein I-17 and E13 are represented by 5- ([ 1,1':3',1 '-terphenyl ] -5' -yl) -7-chloro-2,10,13-trimethylphenyl-8-methyl-5H-5, 15 b-diaza-15 c-borabenzo [ gh ] indeno [1,2,3-no ] tetraphenyl and 3-cyanophenyl boronic acid (CAS: 150255-96-2), respectively.

MS (LC-MS, APPI ion source): 663m/z, rt is at: 8.59min.

Example 10 (0.001 mg/mL in toluene) had an emission maximum at 449nm and a full width at half maximum (FWHM) of 33nm, CIEx coordinates of 0.14, CIEy coordinates of 0.07, PLQY of 77%.

Example 11

Example 11 was synthesized according to the following steps:

AAV16 (60% yield), wherein I-11 and E11 are represented by 4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) -N- (3, 5-di-tert-butylphenyl) naphthalen-2-amine and 6-bromo-9-phenyl-2, 3,4, 9-tetrahydro-1H-carbazole, respectively;

AAV13b (36% yield), wherein I-8b is represented by N- (4- (3, 6-di-tert-butyl-9H-carbazol-1-yl) naphthalen-2-yl) -N- (3, 5-di-tert-butylphenyl) -9-phenyl-2, 3,4, 9-tetrahydro-1H-carbazol-6-amine.

MS (LC-MS, APPI ion source): 863m/z, rt is at: 8.73min.

The emission maximum of example 11 (0.001 mg/mL in toluene) was 533nm and full width at half maximum (FWHM) was 40nm, CIEx coordinates were 0.35, CIEy coordinates were 0.63, PLQY was 84%.

Example 12

Example 12 was synthesized according to the following steps:

AAV7b (56% yield), wherein E4b is represented by 5-bromo-7H-benzo [ c ] carbazole (CAS: 131409-18-2);

AAV9b (76% yield), wherein E4c and E5b are represented by 5-bromo-10-chloro-7H-benzo [ c ] carbazole and 2, 6-dimethylphenylboronic acid (CAS: 100379-00-8), respectively;

AAV10E (60% yield), wherein E9b and I-14b are represented by 5, 10-bis (2, 6-dimethylphenyl) -7H-benzo [ c ] carbazole and 1-bromo-2, 5-dichloro-3-fluorobenzene (CAS: 202865-57-4), respectively;

AAV12d (54% yield), wherein E15b and E3 are represented by 7- (3-bromo-2, 5-dichlorophenyl) -5, 10-bis (2, 6-dimethylphenyl) -7H-benzo [ c ] carbazole and 1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -3, 6-di-o-tolyl-9H-carbazole, respectively;

AAV18 (99% yield), wherein I-18 is represented by 7- (2, 5-dichloro-3- (3, 6-di-o-tolyl-9H-carbazol-1-yl) phenyl) -5, 10-bis (2, 6-dimethylphenyl) -7H-benzo [ c ] carbazole;

AAV19 (92% yield), wherein I-19 and E5b are represented by 7- (2, 5-dichloro-3- (9-methyl-3, 6-di-o-tolyl-9H-carbazol-1-yl) phenyl) -5, 10-bis (2, 6-dimethylphenyl) -7H-benzo [ c ] carbazole and o-tolylboronic acid (CAS: 16419-60-6), respectively.

AAV20 (5% yield), wherein I-19 is represented by 7- (4-chloro-2 '-methyl-5- (9-methyl-3, 6-di-o-tolyl-9H-carbazol-1-yl) - [1,1' -biphenyl ] -3-yl) -5, 10-bis (2, 6-dimethylphenyl) -7H-benzo [ c ] carbazole.

MS (LC-MS, APPI ion source): 946m/z, rt is at: 9.16min.

Example 12 (0.001 mg/mL in toluene) had an emission maximum at 451nm and a full width at half maximum (FWHM) of 18nm, CIEx coordinates of 0.15, CIEy coordinates of 0.07, PLQY of 75%.

Example 13

Example 13 was synthesized according to the following procedure:

AAV10E (80% yield), wherein E9b and I-14b are represented by 3, 6-bis (2-methylphenyl) -9H-carbazole (CAS: 850264-86-7) and 2-bromo-1-chloro-4-fluorobenzene (CAS: 201849-15-2), respectively;

AAV12d (30% yield), wherein E15b and E3 are represented by 9- (3-bromo-4-chlorophenyl) -3, 6-di-o-tolyl-9H-carbazole and 1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -3, 6-di-o-tolyl-9H-carbazole, respectively;

AAV19 (77% yield), wherein I-19 and E5b are represented by 1- (2-chloro-5- (3, 6-di-o-tolyl-9H-carbazol-9-yl) phenyl) -3, 6-di-o-tolyl-9H-carbazole and 3, 5-di-t-butylphenylboronic acid (CAS: 197223-39-5), respectively.

AAV13b (47% yield), wherein I-8b is represented by 1- (3 ',5' -di-tert-butyl-4- (3, 6-di-o-tolyl-9H-carbazol-9-yl) - [1,1' -biphenyl ] -2-yl) -3, 6-di-o-tolyl-9H-carbazole and boron tribromide (99%, CAS No. 10294-33-4) is replaced with boron triiodide (CAS: 13517-10-7).

MS (LC-MS, APPI ion source): 966m/z, rt is at: 9.39min.

Example 13 (0.001 mg/mL in toluene) had an emission maximum at 456nm and a full width at half maximum (FWHM) of 34nm, CIEx coordinates of 0.14, CIEy coordinates of 0.10, PLQY of 95%.

Example 14

Example 14 was synthesized according to the following steps:

AAV10E (96% yield), wherein E9b and I-14b are represented by 3, 6-diphenylcarbazole (CAS: 56525-79-2) and 1-bromo-2-chloro-4-fluorobenzene (CAS: 110407-59-5), respectively;

AAV6 (73% yield), wherein E2a and E5 are represented by 9- (4-bromo-3-chlorophenyl) -3, 6-diphenyl-9H-carbazole and 1,1':3', 1' -terphenyl-5 ' -boronic acid (CAS: 128388-54-5), respectively, and wherein [1,1' -bis (diphenylphosphino) ferrocene is used]Palladium (II) dichloride (CAS: 72287-26-4) replaces Pd (PPh) ₃ ) ₄ ；

AAV12b (41% yield), wherein I-5b and E3 are represented by 9- (2-chloro-5 '-phenyl- [1,1':3', 1' -terphenyl ] -4-yl) -3, 6-diphenyl-9H-carbazole and 1- (tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole (CAS: 1219637-88-3), respectively.

AAV13b wherein I-8b is represented by 9- (2- (9H-carbazol-1-yl) -5 '-phenyl- [1,1':3', 1' -terphenyl ] -4-yl) -3, 6-diphenyl-9H-carbazole and boron tribromide (99%, CAS No. 10294-33-4) is replaced with boron triiodide (CAS: 13517-10-7).

MS (LC-MS, APPI ion source): 663m/z, rt is at: 7.81min.

The emission maximum of example 14 (0.001 mg/mL in toluene) was 460nm and the full width at half maximum (FWHM) was 37nm, the CIEx coordinates were 0.14, and the CIEy coordinates were 0.12.

Example 15

Example 15 was synthesized according to the following procedure:

AAV10E (29% yield), wherein E9b and I-14b are represented by 3, 6-bis (2-methylphenyl) -9H-carbazole (CAS: 850264-86-7) and 1-bromo-2, 5-dichloro-3-fluorobenzene (CAS: 202865-57-4), respectively;

AAV12d (50% yield), wherein I-15b and E3 are represented by 9- (3-bromo-2, 5-dichlorophenyl) -3, 6-di-o-tolyl-9H-carbazole and 9-methyl-1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -3, 6-di-o-tolyl-9H-carbazole, respectively;

AAV19 (71% yield), wherein I-19 and E5b are represented by 1- (2, 5-dichloro-3- (3, 6-di-o-tolyl-9H-carbazol-9-yl) phenyl) -9-methyl-3, 6-di-o-tolyl-9H-carbazole and 3, 5-di-tert-butylphenylboronic acid (CAS: 197223-39-5), respectively;

AAV20 (15% yield), wherein I-20 is represented by 1- (3 ',5' -di-tert-butyl-4-chloro-5- (3, 6-di-o-tolyl-9H-carbazol-9-yl) - [1,1' -biphenyl ] -3-yl) -9-methyl-3, 6-di-o-tolyl-9H-carbazole.

MS (LC-MS, APPI ion source): 966m/z, rt is at: 9.73min.

Example 15 (0.001 mg/mL in toluene) has an emission maximum at 451nm and a full width at half maximum (FWHM) of 24nm, CIEx coordinates of 0.14, CIEy coordinates of 0.07, PLQY of 93%.

Example 16

Example 16 was synthesized according to the following steps:

AAV10E (82% yield), wherein E9b and I-14b are represented by 3, 6-diphenylcarbazole (CAS: 56525-79-2) and 2-bromo-1-chloro-4-fluorobenzene (CAS: 201849-15-2), respectively;

AAV12d (33% yield), wherein I-15b and E3 are represented by 9- (3-bromo-4-chlorophenyl) -3, 6-diphenyl-9H-carbazole and 3, 6-bis (phenyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole, respectively;

AAV19 (44% yield), wherein I-19 and E5b are represented by 1- (2-chloro-5- (3, 6-diphenyl-9H-carbazol-9-yl) phenyl) -3, 6-diphenyl-9H-carbazole and phenylboronic acid (CAS: 98-80-6), respectively;

AAV13b (96% yield), wherein I-8b is represented by 1- (4- (3, 6-diphenyl-9H-carbazol-9-yl) - [1,1' -biphenyl ] -2-yl) -3, 6-diphenyl-9H-carbazole, and wherein boron tribromide (99%, CAS No. 10294-33-4) is replaced with boron triiodide (CAS: 13517-10-7).

MS (LC-MS, APPI ion source): 797m/z, rt is at: 9.95min.

Example 16 (0.001 mg/mL in toluene) had an emission maximum at 462nm and a full width at half maximum (FWHM) of 27nm, CIEx coordinates of 0.13, CIEy coordinates of 0.12, PLQY of 91%.

Example 17

Example 17 was synthesized according to the following procedure:

AAV10E (93% yield), wherein E9b and I-14b are represented by 3, 6-bis (2, 6-dimethylphenyl) -9H-carbazole (CAS: 1246891-46-2) and 1-bromo-2-chloro-4-fluorobenzene (CAS: 110407-59-5), respectively;

AAV6 (84% yield), wherein E2a and E5 are represented by 9- (4-bromo-3-chlorophenyl) -3, 6-bis (2, 6-dimethylphenyl) -9H-carbazole and 4, 5-tetramethyl-2- (2-methylphenyl) -1,3, 2-dioxaborolan (CAS: 195062-59-0), respectively, and wherein [1,1' -bis (diphenylphosphino) ferrocene is used]Palladium (II) dichloride (CAS: 72287-26-4) replaces Pd (PPh) ₃ ) ₄ ；

AAV12b (38% yield), wherein I-5b and E3 are represented by 9- (2-chloro-2 '-methyl- [1,1' -biphenyl ] -4-yl) -3, 6-bis (2, 6-dimethylphenyl) -9H-carbazole and 3, 6-bis (phenyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole, respectively, and wherein palladium (II) acetate (CAS: 3375-31-3) and X-Phos (CAS: 564483-18-7) are used in place of tris (dibenzylideneacetone) dipalladium (0) (CAS: 51364-51-3) and S-Phos (CAS: 657408-07-6), respectively.

AAV13b (44% yield), wherein I-8b is represented by 1- (4- (3, 6-bis (2, 6-dimethylphenyl) -9H-carbazol-9-yl) -2 '-methyl- [1,1' -biphenyl ] -2-yl) -3, 6-diphenyl-9H-carbazole, and wherein boron tribromide (99%, CAS No. 10294-33-4) is replaced with boron triiodide (CAS: 13517-10-7).

MS (LC-MS, APPI ion source): 868m/z, rt is at: 8.43min.

The emission maximum of example 17 (2% in PMMA) was at 457nm and the full width at half maximum (FWHM) was 31nm, CIEx coordinates were 0.14, CIEy coordinates were 0.10, PLQY was 81%.

Example 18

Example 18 was synthesized according to the following steps:

AAV10a (72% yield), wherein E9 and I-4a are represented by phenoxazine (CAS: 135-67-1) and 2-chloro-4-iodotoluene (CAS: 83846-48-4), respectively;

AAV12a (80% yield), wherein I-5a and E3 are represented by 10- (3-chloro-4-methylphenyl) -10H-phenoxazine and 3, 6-bis (phenyl) -1- (4, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) -9H-carbazole, respectively, and wherein X-Phos (CAS: 564483-18-7) is used instead of S-Phos (CAS No. 657408-07-6);

AAV13a (12% yield), wherein I-8a is represented by 10- (3, 6-diphenyl-9H-carbazol-1-yl) -4-methylphenyl) -10H-phenoxazine, and wherein boron tribromide (99%, CAS No. 10294-33-4) is replaced with boron triiodide (CAS: 13517-10-7).

MS (LC-MS, APPI ion source): 599m/z, rt is at: 6.78min.

The emission maximum of example 18 (2% in PMMA) was 485nm and full width at half maximum (FWHM) was 54nm, CIEx coordinates were 0.15, CIEy coordinates were 0.40, PLQY was 73%.

Example 19

Example 19 was synthesized according to step 1.

MS (LC-MS, APPI ion source): 925m/z, rt is at: 10.20min.

The emission maximum of example 19 (2% in PMMA) was 487nm and the full width at half maximum (FWHM) was 49nm, the CIEx coordinate was 0.12 and the CIEy coordinate was 0.31.

Example 20

Example 20 was synthesized according to step 2.

The emission maximum of example 20 (2% in PMMA) was at 471nm and the full width at half maximum (FWHM) was 46nm, CIEx coordinates were 0.13 and CIEy coordinates were 0.20. The photoluminescence quantum yield (PLQY) was 72%.

Example 21

Example 21 was synthesized according to step 3.

MS (LC-MS, APPI ion source): 904m/z, rt is at: 8.68min.

The emission maximum of example 21 (2% in PMMA) was 471nm and the full width at half maximum (FWHM) was 33nm, CIEx coordinates were 0.13 and CIEy coordinates were 0.21.

Additional examples of organic molecules

/>

Claims

1. An organic molecule comprising a structure represented by formula I:

wherein,

R ¹ and R is ² Independently of each other selected from the group consisting of: c (C) ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the To be used forC (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ ；

n, m, p, q is an integer selected from 0 and 1,

Wherein n+m=1, and p+q=1;

r is independently at each occurrence an integer selected from the group consisting of 0, 1, 2, 3 and 4;

s is independently at each occurrence an integer selected from the group consisting of 0, 1, 2 and 3;

R ⁵ Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁶ ) ₂ ；OR ⁶ ；Si(R ⁶ ) ₃ ；B(OR ⁶ ) ₂ ；B(R ⁶ ) ₂ ；OSO ₂ R ⁶ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁶ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁶ C＝CR ⁶ 、C≡C、Si(R ⁶ ) ₂ 、Ge(R ⁶ ) ₂ 、Sn(R ⁶ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁶ 、P(＝O)(R ⁶ )、SO、SO ₂ 、NR ⁶ O, S or CONR ⁶ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁶ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁶ ；

wherein, optionally, the substituent R ^a 、R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ And R is ⁶ Any one of which is independently with one or more substituents R ^a 、R ¹ 、R ² 、R ³ 、R ⁴ 、R ⁵ And/or R ⁶ Forming single or multiple ringsAliphatic, aromatic, heteroaromatic and/or benzofused ring systems.

2. The organic molecule of claim 1, wherein R ^H Is hydrogen.

3. The organic molecule of claim 1 or 2, wherein R ¹ And R is ² Independently of each other selected from: c (C) ₁ -C ₆ An alkyl group; and Ph, optionally substituted independently of one another, is selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph,

wherein, optionally, R ¹ And R is ² Together forming a mono-or polycyclic aliphatic and/or aromatic ring system.

4. An organic molecule according to any one of claims 1 to 3, wherein at least one mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzo-fused ring system is composed of R ^a 、R ³ 、R ⁴ 、R ⁵ And R is ⁶ Substituents with one or more further substituents R ^a 、R ³ 、R ⁴ 、R ⁵ And/or R ⁶ Together forming.

5. The organic molecule of any one of claims 1 to 4, wherein R ^a Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; me; ⁱ Pr； ^t Bu；CN；CF ₃ the method comprises the steps of carrying out a first treatment on the surface of the Ph, optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyridyl optionally substituted independently of each other with a compound selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; pyrimidinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more of the group consisting of PhA number of substituents; carbazolyl groups optionally substituted independently of one another by Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; triazinyl groups optionally substituted independently of one another with a compound selected from the group consisting of Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph; n (Ph) ₂ Optionally substituted with one or more substituents independently selected from Me, ⁱ Pr、 ^t Bu、CN、CF ₃ And one or more substituents from the group consisting of Ph;

wherein, optionally, two or more adjacent substituents R ^a Forming a connection point for the ring system selected from the group consisting of:

6. The organic molecule according to any one of claims 1 to 5, comprising a structure of formula IIa-21:

wherein two R ^a2 Independently selected from R ^a And optionally together with each other form a mono-or polycyclic aliphatic, aromatic, heteroaromatic and/or benzofused ring system; and is also provided with

R ^b Independently of each other at each occurrence selected from the group consisting of: hydrogen; deuterium; n (R) ⁵ ) ₂ ；OR ⁵ ；Si(R ⁵ ) ₃ ；B(OR ⁵ ) ₂ ；OSO ₂ R ⁵ ；CF ₃ ；CN；F；Br；I；C ₁ -C ₄₀ Alkyl, optionallySubstituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Alkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₁ -C ₄₀ Thioalkoxy optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkenyl optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₂ -C ₄₀ Alkynyl, optionally substituted with one or more substituents R ⁵ And wherein one or more non-adjacent CH' s ₂ The radicals being optionally substituted by R ⁵ C＝CR ⁵ 、C≡C、Si(R ⁵ ) ₂ 、Ge(R ⁵ ) ₂ 、Sn(R ⁵ ) ₂ 、C＝O、C＝S、C＝Se、C＝NR ⁵ 、P(＝O)(R ⁵ )、SO、SO ₂ 、NR ⁵ O, S or CONR ⁵ Substitution; c (C) ₆ -C ₆₀ Aryl optionally substituted with one or more substituents R ⁵ The method comprises the steps of carrying out a first treatment on the surface of the C ₂ -C ₅₇ Heteroaryl, optionally substituted with one or more substituents R ⁵ 。

7. The organic molecule of any one of claims 1 to 6, wherein R ¹ Is C ₁ -C ₆ An alkyl group.

8. A composition, the composition comprising:

(a) The organic molecule according to any one of claims 1 to 7, in particular in the form of an emitter; and

(b) A host material different from the organic molecule; and

(c) Optionally, a dye and/or a solvent.

9. The composition according to claim 8, comprising 0.1 to 30 wt% (specifically 0.8 to 15 wt%, specifically 1.5 to 5 wt%) of the organic molecule.

10. The composition of claim 8 or 9, wherein the host material comprises a structure represented by formula 4:

wherein,

each Ar is independently selected from the group consisting of: c (C) ₆ -C ₆₀ Aryl optionally substituted with a member selected from the group consisting of C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ (hetero) alkyl groupsIs a residue or residues of (a); c ₃ -C ₅₇ Heteroaryl optionally substituted with a member selected from C ₆ -C ₆₀ Aryl, C ₃ -C ₅₇ Heteroaryl, halogen and C ₁ -C ₄₀ One or more residues of the group consisting of (hetero) alkyl groups; and is also provided with

11. The composition according to any one of claims 8 to 10, comprising TADF material and/or phosphorescent material.

12. An optoelectronic device comprising an organic molecule according to any one of claims 1 to 7 (in particular as a light-emitting emitter) or a composition according to any one of claims 8 to 11.

13. The optoelectronic device of claim 12, wherein the optoelectronic device is selected from the group consisting of:

an organic diode;

organic Light Emitting Diodes (OLED);

a light-emitting electrochemical cell;

OLED sensor;

organic solar cell;

an organic transistor;

organic field effect transistors;

an organic laser; and

a down-conversion element.

14. An optoelectronic device according to claim 12 or 13, comprising:

A substrate;

an anode and a cathode, wherein the anode or the cathode is disposed on the substrate; and

a light emitting layer disposed between the anode and the cathode and comprising the organic molecule or the composition.

15. A method for generating light of a wavelength of 440nm to 560nm, in particular 440nm to 470nm, the method comprising the steps of:

(i) Providing an optoelectronic device according to any one of claims 12 to 14; and

(ii) A current is applied to the optoelectronic device.